rfhg_153807.1

Basic information about the TSS

---

TSS ID: rfhg_153807.1 Species: human Chr: chr12		Start: 76068934 End: 76068990 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000552056.5:-3 GeneID: 4673 HGNC/MGI_ID: HGNC:7637 UniProt_ID: H0YIV4 Nearer transcript ids and distances:

Gene_name: nucleosome assembly protein 1 like 1 Gene_symbol: NAP1L1 Gene_synonyms: MGC23410 MGC8688 NAP1 NAP1L NRP Gene_source: HGNC:7637

TATA-Box annotation

---

Distance to TSS:	15723
Nearest PromoterID:	NM_001330231
Entrez ID:	4673
Nearest Unigene:	Hs.524599
Nearest Refseq:	NM_004537
Nearest Ensembl:	ENSG00000187109
Gene Name:	nucleosome assembly protein 1 like 1
Gene Alias:	NAP1|NAP1L|NRP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.368421
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NAP1L1 p2@NAP1L1 p3@NAP1L1 p4@NAP1L1 p5@NAP1L1 p6@NAP1L1 p7@NAP1L1
Sample		p1@NAP1L1	p2@NAP1L1	p3@NAP1L1	p4@NAP1L1	p5@NAP1L1	p6@NAP1L1	p7@NAP1L1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	309.35	37.40	12.27	4.48	0.58	0.00	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	292.55	40.06	12.75	4.86	1.01	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	313.66	46.49	12.73	6.56	0.96	0.19	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	274.23	31.81	7.28	5.41	0.42	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	280.53	28.57	7.87	5.85	0.90	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	282.77	37.60	12.21	7.17	0.78	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	368.88	55.56	18.08	18.52	1.53	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	320.70	32.46	15.26	14.29	0.24	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	266.29	28.42	10.04	11.54	0.85	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	323.43	19.71	7.54	27.24	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	291.05	21.83	8.08	23.45	0.40	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	302.07	14.23	6.10	21.95	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	454.24	57.87	9.35	2.90	2.58	0.16	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	453.91	68.11	11.28	3.16	3.16	0.45	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	441.08	64.33	8.78	1.32	1.98	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	421.25	70.42	11.32	3.02	2.51	0.75	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	416.28	59.63	10.92	2.40	1.75	0.22	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	434.05	59.05	9.28	0.00	4.22	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	414.26	65.58	14.93	2.67	1.60	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	414.62	58.82	11.43	3.16	0.90	0.60	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	433.43	58.94	11.23	2.14	1.87	0.40	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	477.13	72.67	8.80	2.93	1.38	0.86	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	462.87	66.31	11.76	1.55	1.81	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	429.52	66.01	12.38	5.10	2.43	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	469.28	62.95	9.03	3.87	0.77	1.03	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	421.91	56.34	13.93	1.27	1.90	0.32	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	519.79	79.67	9.89	2.75	1.10	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	537.52	57.52	16.97	3.06	5.19	0.94	4.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	417.70	56.05	9.05	2.75	1.94	1.13	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	441.74	63.16	13.93	3.80	2.35	0.36	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	409.89	65.32	10.68	2.93	0.21	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	399.56	49.82	8.99	2.34	1.17	0.20	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	400.96	68.16	11.61	2.53	2.32	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	645.08	103.09	18.31	5.94	2.47	0.16	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	460.18	55.91	13.09	4.67	1.68	0.56	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	421.00	54.42	11.31	3.26	1.92	0.38	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	429.61	57.43	11.24	3.47	2.04	0.41	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	422.72	53.80	13.70	2.62	1.01	0.00	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	481.05	67.80	13.24	3.51	1.62	0.27	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	454.68	60.02	13.20	4.32	2.40	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	373.83	51.99	13.17	2.59	1.65	0.24	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	483.83	77.44	14.64	3.22	1.90	0.00	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	434.44	53.57	10.76	2.95	2.32	0.21	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	414.17	51.92	9.79	3.85	1.75	0.87	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	445.51	55.41	12.65	3.41	1.41	0.60	2.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	433.42	60.72	13.49	3.02	3.49	0.23	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	394.41	48.70	8.40	2.88	2.16	0.48	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	391.94	56.93	13.41	5.66	0.89	0.30	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	380.84	41.89	9.57	2.63	1.20	0.72	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	368.81	45.09	15.37	3.44	2.63	0.40	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	484.51	55.13	9.84	2.66	1.64	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	446.31	44.03	15.12	4.23	3.34	0.67	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	17448.25	1455.19	419.77	195.89	125.93	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	447.12	39.39	13.13	4.61	1.42	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	421.52	42.09	6.96	2.32	0.33	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2573.02	327.19	104.87	20.97	35.24	0.84	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	771.07	109.76	29.85	4.59	1.84	0.00	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	457.64	30.79	11.99	2.59	0.97	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	360.35	38.86	6.42	3.21	1.61	0.96	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	725.16	65.70	22.63	7.54	0.63	0.00	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	458.99	30.32	11.28	4.94	1.41	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	430.68	34.77	13.46	3.93	0.56	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1120.17	91.56	35.83	11.15	23.88	1.59	8.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	559.26	51.98	18.35	5.10	4.08	0.34	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	412.00	31.19	10.40	2.60	0.65	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	417.81	29.82	8.16	2.48	2.13	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	19913.97	1487.08	533.41	145.48	145.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15115.78	971.39	308.00	118.46	157.95	7.90	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	416.83	23.40	16.09	2.93	1.46	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	454.71	32.23	11.41	0.99	1.49	0.00	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	345.74	33.78	6.10	1.88	0.94	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	380.20	29.48	23.51	1.32	0.66	0.00	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	372.14	24.75	17.01	2.17	2.17	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	322.25	26.91	17.12	1.53	1.22	1.22	0.61
Adipocyte - breast, donor1	11376-118A8	213.66	66.84	21.86	2.22	0.32	1.11	0.16
Adipocyte - breast, donor2	11327-117E4	171.34	39.14	12.19	0.64	0.32	0.48	0.64
Adipocyte - omental, donor1	11473-119C6	274.30	76.46	23.79	3.69	0.25	0.89	0.00
Adipocyte - omental, donor2	11474-119C7	147.26	32.89	16.44	1.49	0.75	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	154.40	40.53	7.37	1.00	0.33	0.00	2.01
Adipocyte - perirenal, donor1	11476-119C9	115.48	25.52	9.57	1.91	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	64.87	8.80	2.20	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	123.75	39.74	14.00	2.71	0.45	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	198.63	37.71	5.21	0.00	1.04	0.17	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	168.97	39.51	10.95	1.17	0.00	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	100.64	18.27	4.12	1.29	0.00	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	155.83	21.19	4.46	0.56	0.56	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	138.14	39.38	4.11	1.18	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	99.58	42.47	8.85	1.53	0.16	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	112.64	27.76	3.23	0.97	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	121.03	34.12	1.60	0.53	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	93.48	33.39	6.12	0.56	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	44.08	19.55	2.08	0.42	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	71.08	21.10	3.52	0.25	0.25	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	74.94	19.96	4.25	0.33	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	49.02	15.22	3.65	0.61	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	91.49	22.32	4.42	1.55	0.22	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	24.02	3.59	1.08	1.08	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	55.11	4.79	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	126.11	17.99	4.50	0.18	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	103.76	8.37	6.69	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	113.00	17.87	1.64	0.00	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	314.33	109.28	19.57	1.95	0.23	0.46	0.46
Anulus Pulposus Cell, donor2	11463-119B5	156.50	37.47	7.10	0.98	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	254.30	41.34	11.23	1.35	0.90	0.90	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	277.85	46.89	16.06	1.30	1.30	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	376.68	66.35	38.52	0.00	6.42	4.28	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	253.49	42.15	21.82	1.79	0.90	1.20	2.69
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	292.13	46.79	24.03	1.26	0.00	0.00	7.59
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	263.37	53.47	9.24	0.66	2.64	4.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	224.17	34.44	13.00	1.30	0.65	1.62	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	243.69	39.81	21.36	2.43	0.00	2.43	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	310.60	67.11	23.76	1.19	0.59	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	266.66	48.21	22.60	1.51	0.38	1.13	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	239.47	31.20	15.96	1.45	0.00	0.73	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	239.47	52.66	7.52	3.76	0.00	1.25	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	303.44	97.03	35.91	2.64	0.16	0.82	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	240.20	25.93	21.84	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	243.53	50.67	20.06	0.90	1.06	2.26	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	226.64	33.75	11.79	2.14	0.00	3.21	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	250.91	49.50	17.95	1.32	1.13	1.70	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	302.03	71.37	17.91	1.60	0.27	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	221.43	29.26	11.71	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	235.52	49.59	18.74	2.16	0.50	1.49	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	262.96	39.62	14.41	4.80	0.00	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	244.27	38.94	10.62	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	247.86	50.09	15.09	1.37	1.54	1.03	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	285.26	58.73	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	246.11	35.44	18.45	1.94	0.49	1.94	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	280.41	52.36	17.83	2.28	0.38	0.76	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	294.36	59.36	16.96	0.00	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	302.12	31.35	14.25	1.14	0.00	3.42	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	257.81	55.80	16.03	1.07	0.64	1.28	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	254.99	54.97	14.45	0.52	1.03	1.81	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	237.89	39.88	12.20	2.35	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	256.92	58.52	14.79	1.29	1.29	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	241.15	45.66	17.12	2.14	0.71	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	216.43	36.85	11.11	2.92	0.00	0.58	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	258.32	59.61	19.27	1.51	0.90	0.60	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	281.55	52.27	14.26	3.56	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	306.15	46.28	27.46	3.56	0.51	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	313.78	58.83	25.47	1.02	0.76	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	250.97	46.38	10.17	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	236.48	37.54	17.69	1.29	0.86	0.86	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	240.05	51.65	18.21	2.12	1.91	0.85	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	238.65	50.75	14.21	2.32	1.45	2.32	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	243.74	32.12	13.23	1.89	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	234.79	46.96	16.27	2.37	1.02	1.36	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	271.01	67.17	16.21	2.32	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	266.18	31.69	6.34	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	261.15	45.03	12.86	1.07	0.43	1.72	1.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	310.46	52.34	16.85	0.60	0.00	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	236.19	26.24	17.50	0.73	0.73	4.37	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	304.13	52.64	22.53	1.38	0.23	0.69	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	402.95	43.36	33.15	2.55	5.10	2.55	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	234.15	76.27	20.08	3.05	0.25	1.78	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	268.99	52.44	16.93	1.65	1.24	0.83	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	283.36	50.80	14.08	0.92	1.22	1.84	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	279.64	38.72	19.60	1.43	0.48	1.43	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	247.46	46.79	14.19	1.33	1.11	2.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	292.95	59.51	24.41	4.58	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	217.68	32.68	14.95	2.22	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	240.43	44.75	15.36	1.59	0.26	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	272.22	45.43	15.99	1.45	1.09	0.73	0.73
Astrocyte - cerebellum, donor1	11500-119F6	98.38	47.53	5.65	0.61	0.25	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	78.90	19.68	1.54	0.00	0.17	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	101.94	9.65	0.63	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	407.84	139.78	21.26	1.74	0.70	1.74	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	395.70	98.84	20.87	4.04	1.62	0.65	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	404.97	80.25	12.98	2.39	2.24	0.60	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	678.94	262.29	18.69	23.74	2.06	0.46	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	628.04	258.21	18.67	29.44	1.88	0.50	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	630.09	281.65	15.70	30.50	1.71	0.11	0.46
Basophils, donor1	12241-129G9	167.90	26.41	2.88	0.52	0.00	0.26	0.26
Basophils, donor2	12242-129H1	372.70	117.26	11.91	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	202.12	46.89	5.14	0.44	0.59	0.00	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	97.67	16.17	2.16	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	25.60	3.20	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	229.55	35.87	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	90.38	17.57	10.67	3.77	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	60.93	14.56	1.25	1.04	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	121.82	13.36	4.15	0.46	0.00	0.23	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	264.16	46.25	13.86	1.26	2.34	0.54	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	873.50	241.46	15.77	11.23	1.85	1.65	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	956.77	260.39	18.63	45.18	2.33	2.33	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1048.86	124.39	10.87	1.60	0.32	4.16	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	920.43	186.15	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	149.91	40.01	3.38	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	257.98	50.67	3.90	0.93	0.37	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	191.00	39.74	5.05	0.66	1.76	0.66	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	142.94	42.74	5.09	0.00	0.57	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	213.04	72.40	5.31	0.00	0.00	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	186.40	52.60	5.26	0.00	0.66	0.66	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	236.92	41.63	8.82	0.00	1.01	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	235.96	39.83	3.32	0.30	0.60	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	226.00	33.64	4.50	0.47	0.95	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	213.26	35.66	6.03	0.00	0.84	0.50	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	231.30	27.60	3.86	0.28	2.48	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	241.98	35.70	4.71	0.00	0.25	1.24	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	196.98	30.54	2.94	0.00	0.39	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	236.27	32.05	3.03	0.18	0.71	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	384.34	66.81	5.66	0.00	0.22	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	241.15	44.48	3.75	0.00	0.94	0.23	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	388.10	57.56	3.70	0.00	1.06	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	309.51	53.25	4.44	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	235.47	43.14	4.76	0.00	1.19	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	244.25	32.33	4.99	0.40	0.40	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	310.84	45.39	9.16	0.21	0.21	0.62	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	276.83	42.55	5.49	0.23	0.69	0.46	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	343.83	52.48	7.01	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	253.58	26.19	3.06	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	207.12	31.74	5.92	0.27	0.54	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	288.38	39.95	4.71	0.00	1.57	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	229.77	38.29	4.63	0.00	1.26	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	261.42	45.93	9.55	0.18	1.84	0.37	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	241.30	30.65	4.23	0.35	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	258.85	30.71	5.70	0.44	0.88	0.44	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	216.75	29.99	3.84	0.70	1.39	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	257.20	39.77	5.58	0.00	2.97	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	394.67	72.21	5.17	0.22	0.22	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	223.58	36.85	4.09	0.41	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	329.39	53.31	5.10	0.00	0.23	0.23	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	344.97	53.59	6.96	0.70	0.46	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	872.07	124.89	22.01	0.87	0.65	1.96	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	740.11	114.80	22.64	0.00	0.46	0.23	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	507.31	81.66	15.60	0.43	0.22	0.87	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	267.69	65.71	11.52	0.31	0.16	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	252.01	63.22	9.61	0.35	0.00	0.70	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	410.71	96.10	15.61	0.22	0.67	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	1317.21	117.89	23.73	0.51	1.02	2.30	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	1716.78	169.28	32.72	0.22	0.66	2.63	3.95
CD14-CD16+ Monocytes, donor3	11911-125G3	1346.65	143.38	24.42	0.63	0.21	2.32	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	764.15	79.26	8.13	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	787.81	97.63	8.81	2.03	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	765.31	92.17	9.32	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	616.72	105.01	5.86	0.00	0.00	1.60	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1001.37	110.97	9.11	0.54	0.00	2.68	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	771.43	91.25	10.53	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	752.98	76.87	10.20	0.78	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	876.66	109.42	7.91	2.64	1.32	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	525.19	58.35	2.47	0.00	0.82	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	528.84	70.37	5.80	0.73	2.18	0.73	1.45
CD19+ B Cells, donor3	11705-123B4	510.38	55.53	2.02	1.51	2.02	1.51	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	227.08	155.97	31.11	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	170.58	109.86	15.98	0.00	0.40	0.40	1.20
CD34+ Progenitors, donor1	11545-120B6	483.95	59.24	2.01	1.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	373.60	106.74	12.92	2.25	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	496.37	110.47	8.27	1.50	0.38	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	824.14	153.55	15.78	2.48	0.45	0.90	0.90
CD4+ T Cells, donor1	11225-116C1	612.00	220.30	10.71	1.79	1.07	1.43	1.07
CD4+ T Cells, donor2	11306-117C1	742.80	139.62	14.08	1.22	3.67	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	634.69	134.20	10.98	0.91	10.37	1.83	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	360.65	95.20	8.93	0.00	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	397.99	110.28	7.19	0.00	0.00	0.22	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	325.98	113.26	7.76	0.29	0.29	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	883.71	145.55	13.75	0.00	2.37	1.42	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	986.76	168.56	8.43	0.70	2.11	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	632.87	105.48	6.59	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	292.50	132.38	15.46	0.87	0.43	0.87	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	217.59	86.93	6.95	1.02	0.68	0.68	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	193.29	75.61	6.29	0.97	0.32	0.81	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	469.37	140.77	9.86	0.45	0.45	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	597.10	167.36	16.07	0.35	0.70	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	572.86	210.75	21.12	0.44	0.00	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	326.77	165.28	11.81	0.84	0.42	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	277.58	86.85	9.35	0.83	1.04	0.83	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	264.30	87.21	7.68	1.00	0.33	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	935.18	181.65	11.15	0.27	1.36	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1030.63	195.62	8.58	0.00	2.14	0.00	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	611.49	121.94	7.17	0.00	0.00	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	353.98	158.54	16.32	0.37	0.37	1.11	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	273.37	113.51	10.61	0.87	0.00	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	238.73	100.24	8.62	0.42	0.42	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	607.23	123.37	14.16	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	650.74	155.10	13.00	0.87	0.87	0.43	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	830.23	179.99	19.61	1.31	0.44	0.00	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	817.03	171.72	15.84	0.49	1.48	3.46	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	679.46	145.86	13.85	0.00	0.92	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	688.14	118.64	16.75	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	639.15	189.97	11.08	0.28	0.28	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	695.93	205.15	16.20	0.25	0.00	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	677.60	186.34	13.86	1.54	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	761.36	174.76	11.46	0.36	0.00	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	678.65	142.65	13.85	0.00	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	372.90	125.72	11.79	0.98	0.65	0.33	1.31
CD8+ T Cells, donor2	11307-117C2	419.36	93.48	9.01	2.63	3.38	0.75	1.88
CD8+ T Cells, donor3	11383-118B6	592.59	121.70	6.82	1.26	5.55	1.26	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	212.42	67.90	6.88	6.42	0.23	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	196.75	71.17	7.43	6.71	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	229.82	99.04	15.05	6.02	1.92	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	275.89	69.05	17.41	12.01	0.60	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	189.11	69.12	10.32	7.44	0.96	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	206.47	67.76	10.00	6.14	0.45	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	163.40	68.44	10.65	9.56	0.43	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	172.14	74.49	7.90	11.32	0.79	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	179.17	68.01	11.02	10.08	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	190.79	83.92	14.19	13.58	0.60	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	196.38	88.89	13.07	12.78	0.58	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	181.97	68.47	16.52	8.53	1.07	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	198.30	37.21	6.57	3.94	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	207.68	31.88	7.29	4.10	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	196.91	34.31	1.49	3.73	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	217.89	57.99	7.92	8.64	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	197.66	60.71	7.48	7.48	0.58	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	176.54	58.22	7.07	6.36	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	191.73	64.97	15.53	10.46	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	178.69	69.82	11.38	10.76	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	169.59	65.08	14.75	8.66	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	195.82	72.67	14.92	10.71	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	171.44	65.82	14.58	9.46	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	180.78	74.88	11.35	5.29	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	217.60	46.57	5.62	5.62	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	236.41	44.06	7.69	6.99	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	263.46	28.05	4.01	12.02	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	226.64	65.80	9.14	0.00	3.66	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	204.55	33.10	9.39	1.98	0.00	0.49	1.98
Cardiac Myocyte, donor3	11686-122I3	291.70	69.14	20.42	4.00	0.11	0.84	0.42
Chondrocyte - de diff, donor1	11261-116G1	117.17	49.92	18.72	0.69	0.00	0.00	2.08
Chondrocyte - de diff, donor2	11338-117F6	103.77	24.88	5.69	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	260.33	40.85	9.22	0.34	1.02	0.91	0.91
Chondrocyte - re diff, donor2	11339-117F7	212.18	67.14	20.59	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	149.63	14.96	7.28	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	503.67	137.71	24.56	4.93	1.38	1.15	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	328.56	59.43	11.76	2.78	1.28	1.07	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	330.36	69.12	15.04	2.83	2.21	0.80	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	126.36	36.50	5.59	0.46	0.28	0.00	0.09
Corneal Epithelial Cells, donor1	11526-119I5	58.19	15.81	2.63	0.00	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	43.23	11.38	1.14	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	81.29	16.10	3.07	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	111.11	50.85	7.59	0.66	0.33	0.66	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	118.59	48.57	7.89	1.26	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	148.38	65.56	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	112.31	27.86	5.62	0.97	0.76	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	288.35	82.68	3.07	0.00	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	483.78	105.76	2.61	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	259.88	73.08	3.39	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	193.79	47.20	7.67	0.83	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	142.00	25.82	3.52	1.17	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	209.55	36.76	7.64	0.57	0.00	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	273.26	38.14	7.86	1.18	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	124.20	25.02	7.85	0.87	0.00	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	255.51	44.47	13.41	3.29	0.94	0.24	2.35
Endothelial Cells - Artery, donor3	11413-118E9	187.41	33.83	6.66	1.58	0.35	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	300.56	58.07	12.63	1.11	0.44	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	267.45	65.11	12.78	1.83	0.30	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	257.10	61.74	10.71	0.85	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	93.89	40.71	5.65	0.89	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	144.22	39.57	5.73	1.56	0.00	0.00	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	167.45	22.40	5.53	0.28	0.85	0.00	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	203.26	76.42	24.41	3.60	0.00	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	115.83	19.39	4.72	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	652.04	175.93	42.62	6.59	0.87	1.12	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	378.69	74.09	17.60	2.61	0.43	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	367.85	77.06	19.05	5.62	0.12	0.00	0.61
Endothelial Cells - Vein, donor1	11267-116G7	75.08	13.65	3.41	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	83.12	17.46	4.89	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	168.78	20.88	4.71	0.63	0.94	0.31	0.79
Eosinophils, donor1	12244-129H3	716.61	137.22	45.74	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	130.37	36.31	8.25	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	135.54	42.80	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	77.70	19.55	1.47	0.24	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	43.68	2.08	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	244.03	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	206.90	40.64	18.88	2.05	0.41	2.05	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	174.74	38.87	21.02	2.41	1.86	0.00	1.09
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	247.55	45.39	16.47	1.30	0.22	0.11	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	368.21	99.45	42.93	6.43	0.61	0.97	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	194.74	140.97	50.08	4.37	0.00	0.41	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	309.66	61.59	18.98	1.48	0.84	0.11	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	106.71	45.06	18.97	1.32	0.26	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	279.05	64.78	31.56	2.99	1.00	1.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	238.15	38.56	10.89	1.36	0.45	0.91	1.81
Fibroblast - Cardiac, donor2	11345-117G4	124.30	27.29	6.82	0.00	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	194.31	28.23	13.41	0.79	1.58	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	287.95	94.87	28.80	3.94	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	241.37	44.67	12.56	1.65	0.76	0.38	0.89
Fibroblast - Cardiac, donor6	11460-119B2	170.85	52.91	17.28	2.43	0.15	0.00	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	135.06	37.79	4.02	0.54	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	279.57	41.42	9.06	0.00	0.43	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	358.87	45.41	17.58	0.00	7.32	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	133.77	12.69	2.31	1.85	0.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	641.44	169.94	16.45	1.36	0.51	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	127.25	38.27	13.62	3.99	0.00	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	139.62	51.41	12.26	1.42	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	212.16	49.20	24.06	3.51	0.60	1.09	0.97
Fibroblast - Dermal, donor4	11450-119A1	254.80	68.73	22.38	4.18	0.11	0.45	1.58
Fibroblast - Dermal, donor5	11454-119A5	234.12	68.91	18.32	3.66	0.35	0.35	1.05
Fibroblast - Dermal, donor6	11458-119A9	281.80	84.95	29.72	4.87	0.65	0.81	0.81
Fibroblast - Gingival, donor1	11237-116D4	250.50	92.25	36.86	3.75	0.21	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	275.36	74.93	36.94	2.62	1.31	0.52	1.05
Fibroblast - Gingival, donor2	11318-117D4	306.66	67.47	21.22	1.05	1.19	1.19	0.79
Fibroblast - Gingival, donor3	11394-118C8	358.03	62.85	15.86	1.35	0.68	0.19	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	116.36	51.94	18.70	1.04	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	167.57	37.00	8.28	1.23	0.53	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	233.38	70.00	24.79	3.12	1.56	0.00	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	201.49	76.81	24.75	2.70	0.14	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	46.58	10.23	5.65	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	220.10	65.23	18.43	3.07	0.00	0.15	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	211.07	73.09	25.36	1.91	0.55	0.41	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	230.58	66.69	28.96	3.07	0.33	0.22	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	205.43	48.72	9.24	0.15	0.73	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	62.53	9.52	1.36	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	264.11	76.10	34.32	4.48	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	229.82	48.75	19.63	1.48	1.48	1.06	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	60.81	49.15	3.33	2.50	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	100.70	15.38	4.20	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	33.59	7.84	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	231.00	51.96	13.80	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	91.87	7.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	208.47	11.91	17.87	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	301.63	99.12	31.81	2.91	0.39	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	399.07	77.81	25.03	2.88	0.61	0.61	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	220.92	115.05	46.51	5.20	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	140.82	34.35	14.88	1.14	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	172.25	38.61	10.53	0.27	0.54	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	148.10	26.21	6.84	0.12	0.46	0.23	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	269.04	89.53	38.69	6.96	0.11	1.88	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	154.83	39.22	5.49	0.81	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	104.91	20.71	3.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	262.52	46.65	14.63	0.40	0.40	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	193.68	77.20	24.41	1.59	0.00	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	266.43	56.84	13.68	0.71	0.18	0.18	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	290.31	66.81	19.12	1.38	0.39	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	114.63	48.44	20.16	0.90	0.00	0.30	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	294.17	90.57	29.36	2.91	0.11	0.11	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	79.47	41.50	15.69	0.00	0.25	0.25	1.27
Fibroblast - skin normal, donor1	11553-120C5	237.09	57.10	18.70	0.66	0.00	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	126.12	92.23	38.10	1.40	0.80	0.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	209.26	83.38	31.65	2.41	0.10	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	134.19	72.23	26.29	0.60	0.00	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	354.83	77.71	19.63	1.08	0.83	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	411.48	102.40	22.74	1.54	0.17	0.00	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	115.28	46.64	20.36	0.99	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	245.75	92.03	36.32	3.62	0.00	0.11	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	187.57	51.62	13.83	1.35	0.34	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	358.65	62.26	24.93	0.94	0.47	0.16	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	3789.33	1817.10	1130.15	44.32	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	81.05	36.60	13.94	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	149.26	53.39	16.12	1.04	0.35	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	153.80	58.29	25.50	2.34	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	163.02	60.81	19.93	4.85	1.02	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	430.24	94.93	5.36	5.36	0.00	6.89	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	532.79	154.41	7.66	7.02	1.91	3.83	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	810.72	201.97	12.84	19.40	3.14	12.27	5.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	673.67	146.43	8.82	1.93	3.86	10.48	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	505.29	109.14	7.31	2.51	2.74	5.71	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	599.94	137.70	9.11	10.30	1.98	7.53	4.36
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	713.18	139.83	7.67	1.06	3.70	9.52	3.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	480.09	99.47	7.50	1.96	0.98	6.52	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	738.51	175.12	10.17	17.25	1.77	7.52	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	827.87	90.30	11.87	6.36	3.39	3.82	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	568.30	48.76	8.13	4.19	6.28	1.48	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	559.28	128.67	7.79	7.25	2.15	1.61	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	443.91	29.98	6.94	2.85	2.73	0.99	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	596.20	41.39	10.66	8.17	4.01	1.38	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	558.68	103.48	16.47	10.78	4.68	1.42	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	385.62	58.64	5.48	1.14	1.60	1.37	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	475.59	38.99	9.09	3.99	3.61	0.75	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	443.93	64.26	10.71	4.15	3.93	0.87	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	530.39	70.92	7.09	0.59	1.18	2.36	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	553.65	49.75	9.06	1.43	3.97	0.32	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	470.97	67.92	8.94	0.89	5.14	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	537.35	88.32	6.86	1.21	2.22	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	556.09	54.12	12.89	2.54	4.24	1.19	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	563.95	156.42	16.05	5.32	0.62	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	702.38	162.74	12.17	0.83	0.21	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	627.09	153.02	8.88	1.20	0.34	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	548.29	51.34	8.63	0.77	2.66	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	510.82	145.43	11.65	2.08	0.67	1.25	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	482.07	121.28	9.60	3.68	0.41	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	519.89	89.95	9.49	0.62	1.44	1.24	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	556.64	59.95	8.07	0.81	3.69	1.27	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	398.57	68.04	8.17	0.50	2.17	1.83	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	446.59	77.37	6.61	0.44	2.65	0.66	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	676.09	49.32	7.63	0.98	3.20	1.23	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	420.31	60.78	11.67	0.97	5.67	0.81	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	588.51	72.16	6.09	0.00	5.77	2.25	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	407.16	35.91	6.54	0.19	4.26	0.95	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	359.69	54.25	7.43	0.95	2.85	1.27	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	420.86	61.43	8.51	0.61	2.13	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	363.69	31.05	7.84	0.63	2.93	1.67	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	399.37	61.48	7.25	0.22	2.63	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	351.53	50.22	5.89	0.84	2.52	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	275.54	28.98	8.33	0.74	1.57	0.46	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	288.53	62.04	11.23	1.07	1.07	1.07	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	227.52	43.30	9.33	1.22	1.22	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	242.62	22.28	8.68	1.04	0.39	0.52	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	303.33	54.49	8.67	0.27	1.63	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	345.66	59.18	8.30	0.37	1.47	0.55	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	400.90	55.05	10.09	0.66	2.41	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	485.96	62.48	10.91	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	278.60	43.40	7.39	0.79	0.79	0.66	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	265.71	36.32	8.07	0.20	1.21	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	438.43	90.23	12.96	0.76	0.51	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	667.85	234.09	14.13	22.49	0.20	0.80	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	735.41	62.40	8.01	4.47	3.24	1.85	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	907.73	84.29	11.46	8.59	3.48	3.68	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	447.49	123.92	6.57	5.95	0.00	3.76	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	420.73	149.75	11.87	7.63	0.57	3.11	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	465.36	126.83	5.53	16.14	1.38	3.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	490.01	116.32	12.37	9.90	4.95	4.95	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	586.02	135.77	16.63	8.51	1.93	1.93	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	696.34	109.10	3.21	6.42	3.21	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	535.56	100.85	8.69	5.22	0.00	1.74	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	552.66	114.89	9.76	7.81	0.98	4.88	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	621.82	135.48	18.12	4.94	1.24	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	756.42	153.28	16.66	3.33	6.66	10.00	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	568.52	112.70	11.75	6.15	0.84	2.80	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	579.49	114.40	7.52	3.27	0.33	3.92	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	707.98	156.86	19.29	2.52	10.90	6.71	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	665.41	141.54	9.22	3.18	2.23	2.54	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	644.00	127.71	6.11	4.76	1.70	3.06	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	666.12	129.47	8.35	8.35	4.18	8.35	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	907.16	155.77	9.16	4.01	0.57	2.86	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	548.75	82.88	3.26	3.55	0.59	5.03	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	687.82	103.34	30.49	6.78	6.78	1.69	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	709.95	123.02	12.84	2.49	0.83	2.49	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	659.78	120.82	9.44	2.07	1.61	3.22	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	579.53	121.18	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	662.73	102.64	8.46	1.92	2.31	3.08	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	560.67	98.12	5.87	1.30	0.98	1.63	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	508.32	84.94	3.34	2.01	2.01	2.68	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	950.46	152.57	8.09	3.08	1.93	1.54	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	669.96	132.14	8.56	1.71	1.03	1.71	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	730.53	86.97	17.39	0.00	9.94	2.48	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	984.75	137.78	9.91	0.94	2.36	4.72	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	881.70	108.03	4.22	1.81	0.60	6.03	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	978.69	99.19	6.10	1.53	2.54	2.03	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	910.95	139.19	9.57	3.59	2.39	2.39	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	842.16	135.67	8.39	2.47	1.97	2.96	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1181.62	74.37	7.08	3.54	5.90	1.18	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	857.67	102.10	9.92	0.58	2.92	4.67	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	808.42	93.48	3.95	0.44	1.32	2.19	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	712.06	72.90	5.93	0.00	2.54	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	457.83	50.74	7.16	0.00	1.19	5.97	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	464.87	77.64	9.22	0.97	2.91	0.97	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	59.35	10.27	3.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	117.68	31.19	9.15	0.42	0.42	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	74.21	21.36	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	307.33	52.97	14.59	0.32	2.22	0.32	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	223.07	46.37	15.87	2.09	0.00	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	207.48	71.37	12.76	4.06	0.81	0.70	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	205.09	64.99	14.35	1.52	0.17	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	207.03	66.66	8.87	1.82	0.23	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	219.16	65.69	12.13	3.06	0.98	1.09	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	206.53	65.76	13.32	2.36	0.43	0.43	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	200.43	63.29	9.69	2.37	0.65	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	227.41	64.26	12.70	2.24	0.75	0.75	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	197.45	59.70	9.09	2.06	0.86	0.86	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	210.80	41.97	12.49	2.56	0.64	0.64	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	87.86	17.35	0.00	0.56	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	84.39	7.79	0.43	1.30	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	237.94	50.23	13.22	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	80.42	20.81	3.53	1.06	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	92.99	15.26	0.73	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	173.44	45.28	18.88	2.97	0.35	0.87	1.22
Hepatocyte, donor1	11523-119I2	46.00	10.90	2.42	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	84.03	17.24	0.00	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	93.26	12.27	3.68	1.23	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	319.16	132.50	9.14	0.00	1.31	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	357.60	47.02	10.14	1.05	0.17	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	214.32	83.01	23.46	3.16	0.00	0.27	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	3.18	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	20.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	19.38	4.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	7.51	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	178.02	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	15.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	21.12	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	48.35	21.67	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	14.52	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	68.82	21.18	3.97	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	11.09	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	26.19	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	78.10	13.86	2.52	3.78	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	40.21	21.65	3.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	62.67	9.69	3.88	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	8.05	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	66.82	13.04	2.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.33	14.69	1.26	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	82.78	17.68	2.41	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	53.55	17.54	2.77	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	74.58	17.47	2.36	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	55.33	18.14	0.91	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	61.34	6.46	2.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	6.35	3.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.74	8.93	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	52.86	10.94	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	58.55	10.00	3.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	107.41	16.05	4.32	1.23	0.62	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	12.29	1.76	1.76	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	12.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	47.29	8.34	1.39	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	13.28	4.43	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	19.45	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.96	7.85	1.74	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	11.25	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	41.81	10.45	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	49.07	6.40	4.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	41.56	9.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	19.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	8.28	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	12.10	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	24.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	54.98	5.29	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	154.22	62.83	26.52	3.26	0.08	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	65.01	16.98	4.69	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	264.75	63.70	27.54	2.75	1.51	0.28	1.42
Keratinocyte - oral, donor1	11251-116E9	699.61	150.86	39.96	3.75	1.93	0.79	0.79
Keratocytes, donor1	11527-119I6	71.52	7.91	1.72	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	77.34	23.44	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	277.23	20.95	2.17	0.79	2.37	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	296.72	19.78	17.58	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	226.54	30.20	10.79	2.16	2.16	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	422.35	95.73	11.42	1.61	0.46	0.81	0.69
Lens Epithelial Cells, donor3	11690-122I7	174.88	71.65	18.37	2.32	1.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	253.64	52.53	7.47	1.66	0.59	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	197.03	42.14	6.42	1.95	0.56	1.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	300.18	57.30	14.64	1.89	2.20	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	167.77	25.81	9.14	1.08	0.00	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	179.01	26.79	4.10	0.32	4.10	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	148.35	24.69	3.23	0.65	0.75	0.43	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	208.48	36.94	11.08	1.64	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	124.64	19.72	2.28	0.25	1.26	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	183.82	34.20	5.49	0.84	0.56	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	230.60	41.14	8.70	0.40	0.40	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	228.98	44.79	7.37	0.97	1.74	0.97	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	84.24	14.63	0.93	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	232.05	48.78	8.01	0.70	1.39	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	199.41	31.01	4.53	0.48	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	159.60	31.45	3.98	0.55	0.69	0.41	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	222.96	37.57	10.16	2.46	0.92	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	111.92	20.26	3.12	0.62	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	158.10	28.73	2.56	0.91	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	223.47	37.52	10.20	0.66	1.65	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	143.51	24.02	2.05	0.00	0.29	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	114.51	18.42	1.99	0.75	0.00	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	226.48	41.22	11.64	4.85	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	235.10	32.85	5.92	1.08	0.81	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	174.69	24.83	5.75	1.67	0.45	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	190.26	34.73	8.29	2.07	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	261.95	43.13	8.59	1.47	0.84	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	159.69	23.76	2.86	1.05	0.75	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	185.73	33.71	6.19	2.06	0.00	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	207.90	32.36	5.08	0.94	0.19	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	137.84	21.95	3.29	0.64	0.64	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	217.58	30.04	6.78	2.42	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	170.36	31.42	4.96	0.66	0.66	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	125.63	22.92	3.10	0.37	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	238.42	50.72	14.07	1.11	1.11	1.48	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	204.83	29.16	4.20	1.48	0.25	0.49	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	126.36	18.84	1.79	0.41	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	238.33	49.85	7.40	1.29	1.61	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	257.46	45.95	7.61	2.13	0.91	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	234.30	42.41	8.96	1.12	1.40	0.70	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	214.05	37.69	9.24	0.71	0.71	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	138.65	20.36	2.91	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	91.34	16.81	0.93	0.47	0.47	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	186.57	24.35	2.86	1.43	1.07	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	161.38	23.52	1.96	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	77.69	13.65	1.65	0.00	0.71	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	211.99	49.62	6.68	0.99	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	110.39	15.62	2.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	128.00	21.48	2.09	0.60	0.00	0.30	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	222.07	36.26	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	133.48	13.04	3.84	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	133.60	20.04	2.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	160.79	26.66	1.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	142.07	19.69	2.81	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	141.03	17.75	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	185.50	23.19	2.58	0.52	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	139.17	17.84	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	183.67	33.70	2.49	0.00	0.23	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	261.16	42.46	2.62	0.29	1.16	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	233.19	33.76	2.70	0.00	0.45	0.00	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	223.15	50.13	3.12	0.27	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	164.84	33.38	1.54	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	203.24	31.40	3.53	0.00	0.00	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	211.22	29.32	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	190.51	30.56	2.55	1.02	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	241.73	32.02	2.13	0.27	0.27	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	271.89	37.41	3.59	0.76	0.38	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	163.21	25.77	1.23	0.61	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	196.52	21.20	2.45	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	284.25	41.65	5.21	0.00	1.04	0.00	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	275.50	54.93	5.32	0.28	0.00	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	170.01	29.88	0.00	0.00	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	277.53	41.80	6.39	0.87	0.87	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	246.32	40.36	6.58	0.00	1.20	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	209.68	27.66	2.77	0.55	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	230.47	31.46	3.53	0.35	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	208.73	46.84	1.84	0.00	1.48	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	112.82	26.48	2.30	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	189.57	28.40	2.30	0.77	1.15	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	199.84	34.53	1.70	1.13	2.83	0.00	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	155.89	25.43	1.64	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	182.11	17.17	1.36	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	193.18	42.37	1.44	0.00	0.72	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	177.76	20.91	3.73	0.75	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	214.78	36.79	4.46	0.00	1.11	0.00	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	183.07	34.03	3.02	0.00	0.43	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	136.15	21.41	5.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	191.24	33.65	5.66	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	120.66	28.96	2.41	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	98.12	9.95	0.71	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	170.14	27.15	3.44	0.34	0.00	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	129.36	33.28	1.07	0.54	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	111.78	17.51	0.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	189.28	30.37	2.22	0.00	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	176.77	48.84	2.33	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	81.45	12.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	189.67	29.61	1.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	125.75	15.26	1.45	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	133.37	16.86	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	159.33	28.12	2.96	0.49	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	109.15	27.29	4.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	133.75	16.09	0.50	0.00	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	196.92	28.39	1.35	0.45	0.00	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	123.92	39.59	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	121.58	23.16	2.23	0.00	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	183.39	26.59	1.96	0.39	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	154.38	25.07	1.98	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	135.96	18.68	1.56	0.00	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	229.28	31.07	3.06	0.88	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	187.30	43.05	3.91	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	144.86	23.41	0.44	0.00	1.32	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	223.71	32.79	3.09	0.77	0.39	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	188.87	41.52	2.53	1.52	2.53	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	173.98	30.76	2.40	0.00	0.96	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	223.82	30.61	3.18	0.80	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	188.97	32.81	2.43	2.43	0.61	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	116.90	20.75	2.08	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	197.60	27.74	3.80	0.00	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	201.92	29.44	5.16	0.52	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	97.35	18.14	2.42	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	231.65	33.27	2.85	0.32	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	155.13	30.39	0.00	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	96.54	16.09	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	208.26	31.37	2.57	0.51	1.54	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	206.55	33.95	2.83	0.00	0.71	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	78.31	15.89	1.70	1.13	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	206.76	28.71	1.25	0.00	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	209.86	50.11	0.78	0.00	0.00	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	88.52	18.79	0.84	0.00	0.00	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	179.81	17.66	1.39	0.46	0.93	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	141.84	28.10	1.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	86.61	14.97	1.07	0.53	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	200.84	30.31	3.23	0.81	0.81	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	104.62	22.03	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	84.47	13.34	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	159.56	12.54	2.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	120.40	24.54	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	112.72	22.98	1.64	0.00	0.00	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	134.53	20.49	1.78	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	141.42	32.23	3.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	75.59	21.88	0.66	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	164.21	18.71	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	67.69	45.13	7.29	0.00	0.23	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	108.27	63.31	15.41	0.73	0.37	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	108.01	41.55	8.52	0.26	0.26	0.13	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	111.51	55.23	18.05	2.66	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	249.88	82.40	51.02	3.64	0.32	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	279.09	97.71	49.48	6.67	0.28	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	181.75	76.63	32.78	4.98	0.30	0.60	0.20
Mammary Epithelial Cell, donor2	11350-117G9	195.45	73.26	31.56	6.66	0.58	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	68.34	16.46	5.74	0.25	0.25	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	763.36	162.03	40.00	4.07	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	157.99	81.75	12.54	0.22	0.32	0.22	0.00
Mast cell, donor2	11565-120D8	206.54	106.39	17.53	2.08	0.59	0.00	0.00
Mast cell, donor3	11566-120D9	224.45	120.22	18.91	2.93	0.23	0.90	0.23
Mast cell, donor4	11567-120E1	183.49	104.96	12.23	3.55	0.18	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	280.56	105.02	26.84	4.10	0.55	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	183.28	86.39	6.42	2.33	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	185.28	97.63	17.90	0.46	0.46	0.11	0.57
Mast cell, expanded, donor8	11941-126A6	203.69	82.68	10.71	0.17	0.17	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	363.47	75.42	10.05	2.69	0.30	0.20	0.50
Melanocyte - dark, donor2	11582-120F7	199.00	39.11	11.07	1.38	1.04	1.38	1.04
Melanocyte - dark, donor3	11663-122F7	113.80	84.76	20.57	0.58	0.43	0.58	0.00
Melanocyte - light, donor1	11274-116H5	45.84	8.70	1.88	0.00	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	38.22	10.92	0.68	0.68	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	69.38	11.27	2.60	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	186.70	20.51	6.98	0.52	0.21	0.42	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	208.16	39.80	7.53	1.08	0.54	1.61	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	185.09	28.12	3.21	0.54	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	164.38	59.42	10.42	1.61	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	145.25	39.61	6.60	1.32	0.00	0.00	0.88
Meningeal Cells, donor3	11654-122E7	411.91	172.38	50.12	6.36	0.49	0.65	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	263.48	102.09	28.52	5.42	0.57	1.14	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	240.41	62.09	21.74	1.41	0.20	0.30	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	30.23	15.77	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	49.71	15.70	0.00	0.00	0.00	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	165.05	40.90	22.96	2.15	2.15	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	195.89	49.77	12.07	0.64	0.21	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	184.47	37.20	11.06	2.01	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	76.69	27.69	6.81	1.54	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	103.74	27.03	5.84	1.46	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	72.84	18.01	4.50	1.02	0.41	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	187.82	93.22	18.84	1.66	0.00	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	83.64	21.56	3.72	0.00	0.37	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	887.73	147.10	30.92	4.61	1.05	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	105.34	24.63	2.67	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	142.47	21.02	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	119.11	25.62	6.40	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	142.49	82.94	33.67	2.13	0.35	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	658.28	115.40	29.40	2.50	1.25	0.63	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	161.83	50.80	13.79	5.08	1.45	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	134.18	48.00	25.46	3.45	0.53	1.33	0.53
Mesothelial Cells, donor2	12156-128G5	119.11	41.04	21.02	2.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	121.26	33.31	18.57	1.16	1.81	0.22	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	85.07	32.41	4.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	157.62	40.64	10.59	0.25	0.25	0.49	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	136.04	45.35	8.54	0.59	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	62.23	3.46	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	146.29	39.98	6.51	0.31	0.31	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	111.18	42.94	7.47	0.41	1.24	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	50.95	11.58	4.63	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	137.64	25.78	6.51	0.00	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	114.51	41.43	6.98	1.40	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	130.06	36.38	6.30	0.20	0.41	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	93.05	33.66	4.36	0.00	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	25.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	112.39	24.78	7.08	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	120.82	47.87	12.92	0.00	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	55.27	6.58	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	123.51	34.17	4.24	0.00	0.85	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	59.85	15.65	3.68	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	111.17	19.08	4.77	0.00	0.89	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	20.12	3.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	129.22	29.36	6.02	0.00	0.25	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	103.39	40.64	4.99	0.48	2.14	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	84.59	8.29	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	126.17	23.72	6.22	0.23	0.23	0.46	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	101.38	38.91	5.05	0.21	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	76.84	19.77	4.48	0.41	0.41	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	130.87	32.82	7.29	0.21	0.43	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	90.47	26.90	5.33	0.22	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	93.52	16.65	3.94	0.66	0.22	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	65.40	19.77	2.53	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	34.80	9.94	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	113.88	22.56	3.53	0.00	0.54	0.27	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	72.64	29.41	2.35	1.18	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	4.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	81.69	13.46	3.36	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	88.05	32.42	5.20	0.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	2.74	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	74.09	17.52	2.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	12.23	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	57.37	11.82	4.82	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	30.90	9.93	4.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	26.26	6.40	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	70.41	17.85	4.46	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	37.58	11.13	6.26	0.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	8.84	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	60.85	15.73	5.13	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	36.32	6.13	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	37.29	3.55	3.55	0.36	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	66.77	17.39	3.09	0.00	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	42.39	12.05	2.08	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	32.63	6.41	1.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	56.11	11.46	3.32	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	60.94	17.53	3.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	60.03	8.31	1.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	48.94	15.37	2.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	56.24	6.22	3.73	0.00	0.14	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	64.53	12.70	2.85	0.00	0.00	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	59.20	20.59	5.15	0.43	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	27.31	4.45	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	55.51	13.34	4.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	74.83	25.14	7.78	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	50.29	9.61	2.54	0.00	0.42	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	54.47	16.56	3.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	64.35	22.56	6.63	0.22	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.64	13.27	2.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	76.42	20.74	5.68	0.00	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	66.61	27.04	3.93	0.25	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	44.31	13.69	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	79.09	21.17	4.70	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	72.37	26.24	5.48	0.29	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	97.68	65.53	20.61	0.41	0.00	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	67.30	22.63	8.34	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	101.71	7.53	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	160.40	33.86	3.56	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	144.24	24.97	5.26	0.00	0.99	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	153.59	19.99	2.10	0.00	0.00	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	184.84	49.22	6.13	0.00	0.40	1.58	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	275.67	43.77	4.66	0.00	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	147.58	31.92	5.63	0.00	0.75	0.00	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	142.49	27.70	6.13	0.00	0.27	1.07	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	133.57	38.34	5.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	112.72	19.89	2.21	0.00	0.74	0.00	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	125.68	19.05	4.03	0.00	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	147.78	31.11	7.78	0.00	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	208.97	62.53	9.09	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	112.05	15.46	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	114.12	19.19	3.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	188.05	18.55	6.32	0.00	1.26	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	217.91	39.50	5.45	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	374.48	55.95	8.90	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	293.97	59.12	12.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	194.85	28.70	7.55	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	154.17	5.71	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	352.34	65.25	9.79	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	104.55	38.02	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	150.59	49.12	14.43	1.72	0.43	0.22	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	251.38	26.13	5.75	0.52	1.05	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	118.81	16.69	13.35	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	46.75	12.10	4.59	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	228.93	41.45	19.20	1.90	0.38	0.19	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	411.73	49.47	28.73	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	83.63	9.52	2.04	2.04	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1148.53	240.73	110.26	7.35	5.51	0.00	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	111.75	15.07	3.77	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	112.04	20.22	10.23	0.46	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	122.95	11.35	5.67	0.27	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	243.45	36.58	10.09	1.05	0.63	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	4754.53	812.83	311.77	22.27	22.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	155.36	23.33	6.95	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	172.96	25.17	8.93	0.27	0.81	0.00	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	113.79	19.04	7.25	0.00	0.68	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	122.80	17.15	4.25	0.00	0.33	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	293.61	42.65	10.94	0.91	0.91	0.18	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	188.84	22.81	5.83	0.00	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	150.68	16.21	4.20	0.00	1.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	438.44	62.03	20.02	0.33	0.98	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	113.67	12.68	4.55	0.33	0.00	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	298.97	36.51	10.41	1.59	0.00	0.18	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	212.38	16.88	5.63	0.70	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	169.63	19.77	3.22	0.00	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	165.81	19.28	4.18	0.64	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	463.18	67.60	20.00	1.72	2.07	0.34	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2432.36	321.11	70.80	12.64	7.59	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	237.49	33.64	9.58	1.56	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	168.51	15.24	2.96	0.42	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	175.88	22.31	6.17	0.00	0.95	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	200.89	21.03	3.86	0.43	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	7502.07	884.72	234.72	81.25	27.08	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	161.95	20.99	4.33	0.33	0.33	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	256.99	24.35	4.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	160.70	28.17	3.17	1.98	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	208.02	20.43	7.43	1.86	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	214.54	22.70	5.30	0.38	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	136.22	16.95	2.93	0.00	0.33	0.00	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	134.66	10.89	2.61	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	309.36	38.44	10.40	4.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	152.57	17.64	3.53	3.53	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	233.36	15.29	5.32	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	198.91	18.85	6.45	0.50	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	122.12	15.70	0.38	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	204.76	25.10	5.14	0.30	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	259.04	37.57	9.95	0.66	0.22	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	201.94	19.65	5.42	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	2871.56	332.12	66.42	30.66	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	206.07	20.12	4.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	123.69	14.79	1.57	1.26	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	170.09	11.20	0.91	0.00	0.91	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	243.67	18.20	3.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	601.96	60.08	14.74	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	3287.63	374.28	131.51	5.06	25.29	0.00	0.00
Myoblast, donor1	11241-116D8	215.91	75.66	25.72	4.35	0.12	0.99	0.50
Myoblast, donor2	11322-117D8	214.80	45.65	17.07	1.73	1.15	1.15	0.38
Myoblast, donor3	11398-118D3	269.40	104.60	34.31	5.72	1.01	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	435.76	78.95	14.59	1.31	2.33	1.17	2.63
Natural Killer Cells, donor1	11230-116C6	299.21	117.16	8.61	1.23	0.92	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	376.95	100.72	10.86	0.60	3.92	1.81	0.30
Natural Killer Cells, donor3	11387-118C1	339.03	80.98	9.94	0.92	3.31	1.66	1.29
Neural stem cells, donor1	11275-116H6	419.92	234.46	42.46	12.34	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	383.20	134.80	36.59	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	383.47	56.89	14.79	0.00	2.28	1.14	1.14
Neurons, donor2	11574-120E8	225.67	74.20	12.55	2.42	0.44	0.44	0.00
Neurons, donor3	11655-122E8	448.08	46.04	22.20	2.47	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	44.54	15.78	2.78	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	72.47	20.29	0.00	2.90	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	76.97	26.88	13.44	4.28	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	519.35	125.15	14.96	1.19	1.54	0.47	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	289.46	52.75	5.86	1.30	0.33	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	199.55	29.08	5.82	0.60	0.20	1.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	235.80	38.68	9.09	0.83	1.24	0.96	0.83
Olfactory epithelial cells, donor2	11934-125I8	278.92	49.36	19.11	1.30	1.01	0.87	1.74
Olfactory epithelial cells, donor3	11935-125I9	239.72	44.72	10.44	0.57	1.93	0.91	0.11
Olfactory epithelial cells, donor4	11936-126A1	294.82	43.93	10.91	0.39	0.97	0.68	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	321.37	73.42	24.67	7.22	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	198.87	50.83	6.38	0.43	0.64	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	85.73	20.58	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	193.66	25.45	5.59	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	100.26	32.44	3.32	0.20	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	191.03	66.02	26.69	4.21	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	143.61	29.68	8.18	0.53	0.53	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	284.21	104.12	43.47	3.87	0.59	1.01	0.34
Pericytes, donor1	11491-119E6	53.07	13.02	0.89	0.33	0.00	0.00	0.22
Pericytes, donor2	11571-120E5	64.51	11.09	1.13	0.23	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	148.72	16.28	4.27	0.61	0.00	0.00	0.61
Perineurial Cells, donor1	11499-119F5	340.08	79.11	25.99	3.39	0.57	0.68	1.47
Perineurial Cells, donor2	11579-120F4	279.62	90.17	18.49	3.68	0.37	0.18	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	401.61	153.95	15.30	1.59	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	401.82	70.52	8.57	2.20	0.98	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	315.52	66.91	4.14	0.91	0.65	0.13	0.26
Placental Epithelial Cells, donor1	11278-116H9	35.64	8.37	2.87	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	164.11	35.48	8.87	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	127.02	13.74	4.52	0.39	0.20	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	128.48	25.63	12.97	1.27	0.95	0.00	0.95
Preadipocyte - breast, donor1	11467-119B9	160.20	59.84	18.20	1.50	0.00	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	172.69	77.92	29.50	1.96	0.13	0.52	0.26
Preadipocyte - breast, donor2	11328-117E5	172.46	32.20	11.48	0.45	0.45	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	198.41	54.77	22.38	1.70	0.11	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	163.68	57.61	16.59	0.44	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	93.54	29.22	14.04	1.72	0.43	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	86.62	19.69	3.94	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	43.61	27.33	7.99	1.23	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	181.50	83.05	37.36	6.02	0.89	0.71	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	149.51	50.23	23.67	3.41	0.68	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	153.79	133.01	57.10	9.87	0.47	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	161.06	91.12	30.37	2.76	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	104.39	52.45	23.20	3.24	0.21	0.42	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	503.24	59.74	7.54	3.47	0.91	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	81.11	23.29	9.75	0.95	0.14	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	337.60	24.01	8.51	0.49	2.45	0.06	1.16
Prostate Stromal Cells, donor1	11254-116F3	239.53	84.86	22.67	3.30	0.34	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	207.45	70.29	25.28	3.59	1.43	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	208.66	54.85	16.58	0.83	0.31	0.63	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	79.20	17.52	1.46	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	314.81	64.53	23.22	1.59	0.49	0.35	0.14
Renal Epithelial Cells, donor1	11517-119H5	36.52	15.72	2.54	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	73.27	12.09	2.85	1.42	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	428.65	109.36	33.98	2.86	0.32	0.32	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	44.26	7.49	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	92.99	21.56	3.37	0.54	0.00	0.27	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	241.77	55.28	15.98	3.77	5.11	0.22	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	36.60	4.66	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	71.09	20.91	3.74	0.88	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	113.48	18.81	1.88	0.00	0.63	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	60.48	6.66	0.83	0.28	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	100.39	27.65	5.37	1.61	0.54	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	101.21	10.96	2.53	0.42	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	127.66	21.21	3.09	0.58	0.39	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	284.17	72.60	21.26	4.41	0.52	1.04	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	200.96	36.10	2.27	0.28	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	90.56	16.47	1.03	0.00	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	538.70	106.64	11.29	1.51	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	248.96	59.33	5.61	0.27	0.00	0.00	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	290.36	93.81	5.36	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	747.95	281.79	39.63	1.10	6.05	0.00	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	601.52	216.94	29.00	1.16	1.74	0.00	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	271.10	176.57	21.45	2.21	0.13	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	307.15	98.41	14.20	0.89	1.69	0.60	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	345.44	193.52	16.95	2.23	0.67	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	405.00	176.76	18.11	1.74	0.87	0.37	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	340.08	122.49	13.64	1.98	1.63	0.82	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	449.78	140.53	18.95	2.54	1.62	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	237.13	85.57	11.23	1.37	0.41	0.14	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	380.15	109.37	15.28	1.06	0.76	0.45	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	246.03	126.51	13.62	1.08	0.00	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	224.08	86.65	12.05	0.72	0.57	0.43	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	318.94	106.67	10.09	1.50	0.75	0.54	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	326.37	100.24	12.61	1.55	0.22	0.89	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	254.84	70.54	9.37	0.76	0.19	0.19	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	311.54	107.70	13.32	1.21	0.75	0.28	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	390.66	253.86	22.36	3.95	0.56	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	244.31	85.46	9.95	0.80	0.27	0.13	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	335.53	116.91	15.28	1.07	1.17	0.58	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	336.85	118.59	16.23	1.53	0.57	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	214.12	86.93	10.89	0.85	0.43	0.32	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	329.64	96.43	16.82	0.56	0.56	0.56	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	306.59	108.18	11.45	1.54	0.34	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	227.91	78.77	7.84	1.28	0.36	0.36	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	284.51	98.72	13.24	1.23	0.61	0.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	315.65	112.83	13.30	1.34	0.40	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	237.29	99.30	10.85	1.42	0.00	0.24	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	305.76	107.14	12.30	1.39	2.18	0.60	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	340.71	105.70	16.84	1.40	0.94	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	227.26	85.64	10.37	0.62	0.41	0.62	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	368.09	159.27	20.13	3.32	0.66	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	278.65	95.67	12.53	1.04	0.84	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	226.51	90.17	11.98	0.94	0.54	0.27	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	268.38	99.96	14.48	0.85	0.68	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	308.86	111.24	10.99	1.35	0.77	0.77	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	269.08	98.35	12.55	1.55	0.69	0.17	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	255.41	96.57	12.35	1.65	0.82	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	370.37	142.01	23.97	1.81	0.99	0.66	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	259.23	78.40	9.37	0.68	0.00	0.51	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	304.64	122.36	16.87	1.78	1.33	0.30	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	263.09	92.76	11.73	0.27	0.53	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	261.05	93.61	6.36	0.41	0.28	0.14	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	299.06	103.10	11.43	0.24	0.24	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	366.81	136.24	10.08	0.81	1.01	0.20	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	240.62	106.13	8.00	0.28	0.00	0.57	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	582.39	133.46	13.63	1.40	2.45	1.05	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	433.68	98.52	7.25	0.30	1.21	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	221.89	114.19	8.57	0.12	0.12	0.24	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	576.39	282.81	34.50	1.31	0.29	0.44	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	459.97	90.05	12.17	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	234.79	110.31	8.44	0.60	0.00	0.00	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	356.47	98.62	7.01	0.45	0.00	0.45	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	367.54	94.36	9.59	1.20	2.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	318.92	138.97	9.92	0.35	0.00	0.12	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	334.68	76.41	7.47	0.21	0.21	0.00	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	362.99	90.75	9.62	2.40	0.60	1.80	0.00
Schwann Cells, donor1	11498-119F4	63.19	17.11	2.44	0.38	0.00	0.00	0.75
Schwann Cells, donor2	11578-120F3	258.58	47.63	6.80	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	186.44	42.28	14.02	1.31	1.31	2.19	0.44
Sebocyte, donor1	11220-116B5	220.20	47.66	13.15	2.74	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	174.63	37.68	7.35	3.22	0.46	0.00	0.46
Sebocyte, donor3	11378-118B1	151.91	22.88	4.33	0.82	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	202.10	61.29	21.54	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	288.09	70.61	36.72	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	283.82	56.31	13.37	2.99	0.35	0.35	0.26
Skeletal Muscle Cells, donor2	11358-117H8	73.01	15.90	2.89	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	96.14	14.21	10.03	3.34	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	207.52	72.11	20.74	4.56	0.31	0.31	0.94
Skeletal Muscle Cells, donor5	11455-119A6	212.86	66.15	13.53	4.76	0.45	0.45	1.04
Skeletal Muscle Cells, donor6	11459-119B1	234.39	79.88	27.09	10.47	0.31	1.39	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	455.51	167.59	36.79	4.54	1.01	0.88	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	323.76	77.05	15.70	2.57	1.57	0.14	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	268.86	76.89	19.25	3.57	1.09	0.69	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	254.69	94.70	17.44	3.88	0.00	0.67	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	120.14	19.54	4.34	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	75.95	15.69	2.89	0.41	0.41	0.41	0.55
Skin - palm, donor1	10286-104F7	96.70	53.72	10.74	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	89.38	18.88	8.65	0.86	0.29	0.00	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	130.86	40.89	32.72	2.45	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	105.29	18.95	7.40	0.52	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	250.08	55.60	20.71	2.78	0.28	1.11	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	178.07	22.79	9.56	1.69	0.42	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	119.47	61.95	26.01	4.23	0.21	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	201.99	15.96	5.40	0.45	0.75	0.00	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	224.03	34.56	17.90	2.16	0.62	0.00	2.78
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	74.93	36.02	20.68	0.89	0.00	0.00	1.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	87.00	35.27	17.05	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	123.53	27.84	8.40	1.33	0.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	61.04	27.56	12.60	1.97	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	102.75	29.36	23.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	512.39	143.11	14.01	1.00	1.00	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	101.67	35.66	11.18	1.06	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	200.38	50.09	20.84	3.55	1.11	0.66	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	143.91	39.82	11.14	4.10	0.00	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	216.84	68.05	12.37	1.63	0.65	1.30	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	167.15	51.09	18.31	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	157.74	31.46	8.26	1.00	0.43	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	49.94	17.24	2.44	0.33	0.16	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	276.12	38.66	9.13	0.00	2.74	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	104.81	33.09	12.12	1.77	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	612.07	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	71.05	21.46	5.72	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	179.18	78.60	17.11	2.36	0.15	1.33	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	168.32	43.69	11.84	1.29	0.43	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	198.79	44.82	12.39	1.47	0.42	0.21	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	87.86	30.16	9.59	1.39	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	67.91	25.87	5.39	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	78.30	23.01	7.47	1.49	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	61.11	23.56	3.76	1.37	0.34	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	744.85	196.72	26.31	3.61	0.94	0.55	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	268.21	81.02	37.24	5.94	0.30	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	103.08	28.22	15.25	2.50	0.23	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	64.00	11.47	7.85	0.60	0.00	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	312.35	173.00	46.89	15.90	0.26	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	112.25	69.78	14.78	2.80	0.00	0.00	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	208.99	56.60	14.90	1.88	0.75	0.50	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	156.51	64.18	16.23	0.25	0.51	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	178.97	73.12	25.93	3.32	0.15	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	111.02	19.50	5.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	534.98	12.92	3.88	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	81.39	29.30	10.70	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	191.86	40.90	23.22	2.52	1.51	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	94.65	23.19	7.83	1.57	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	29.50	17.70	3.24	0.00	0.29	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	184.44	112.88	50.90	8.33	0.08	0.33	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	273.29	51.39	9.34	0.00	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	125.50	43.03	9.93	1.15	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	135.89	25.24	9.43	1.02	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	107.18	21.81	4.32	0.19	0.00	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	238.40	113.05	45.70	5.03	0.00	0.42	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	242.82	65.77	22.20	2.93	0.25	0.92	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	47.62	10.48	3.81	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	113.52	38.41	12.72	0.73	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	146.71	64.07	25.85	2.87	0.00	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	134.00	40.38	28.67	2.63	0.29	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	199.80	29.54	9.33	0.19	0.39	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	118.74	24.59	16.66	0.00	0.00	0.00	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	266.69	87.78	40.17	1.49	1.12	0.37	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	212.01	64.32	25.51	1.08	0.72	0.72	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	107.88	23.28	12.21	1.14	0.28	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	234.35	41.75	25.60	1.18	0.39	0.39	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	210.27	45.71	23.36	2.29	1.27	0.51	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	257.96	54.71	9.98	0.80	1.20	0.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	244.95	32.19	10.87	0.84	0.42	0.42	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	242.93	42.17	5.96	0.46	0.92	1.38	0.46
Synoviocyte, donor1	11291-117A4	225.38	64.30	19.02	1.85	0.17	0.50	0.17
Synoviocyte, donor2	11368-117I9	180.87	44.76	15.09	0.84	0.50	0.67	1.17
Synoviocyte, donor3	11440-118H9	118.63	32.84	8.04	0.67	0.00	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	112.56	27.51	5.36	1.07	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	69.37	15.86	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	95.17	16.90	3.01	1.62	0.23	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	174.69	46.24	13.62	2.08	0.36	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	80.02	13.92	2.32	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	62.42	20.62	1.72	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	248.76	62.74	6.64	0.37	0.37	0.49	0.12
Urethra, donor2	10319-105A4	203.22	52.15	8.99	1.80	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	48.88	10.63	1.59	0.27	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	63.29	7.61	1.60	0.00	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	72.20	6.42	0.92	0.00	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	232.48	40.79	15.60	0.67	0.45	1.11	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	513.40	119.23	55.17	18.69	0.89	0.89	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	431.74	117.23	58.61	44.32	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	461.37	58.87	19.85	8.21	0.68	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	525.12	103.99	24.79	6.20	0.00	1.03	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	505.49	105.75	24.40	9.88	0.00	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	326.95	105.17	43.73	27.07	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	441.46	111.05	58.74	29.37	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	516.70	48.38	27.39	13.69	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	466.31	131.13	18.75	7.03	2.10	0.49	3.45
Wilms' tumor cell line:HFWT	10597-108E3	276.33	25.52	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	291.33	55.03	7.54	2.23	1.96	0.56	0.84
achilles tendon, donor2	10292-104G4	305.85	24.80	12.40	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	391.61	180.76	18.36	18.10	2.55	2.29	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	688.40	203.85	8.82	1.63	0.93	2.09	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	630.93	236.23	14.72	1.90	1.31	0.47	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	385.86	227.76	21.77	5.71	1.63	1.09	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	455.64	122.55	11.24	9.28	2.53	0.56	2.53
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	510.09	81.42	10.36	2.11	0.63	1.27	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	609.48	80.57	7.08	1.36	2.18	0.82	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1070.75	154.66	12.78	2.64	2.64	2.20	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	692.99	83.31	7.35	4.08	2.04	1.63	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	506.73	82.32	5.82	2.72	3.11	0.78	5.05
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	446.75	131.56	12.33	7.73	2.02	0.92	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	955.63	198.93	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	415.50	154.30	23.01	12.08	2.09	1.39	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	635.34	156.38	29.00	1.29	2.33	0.78	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	577.18	150.80	23.09	3.51	3.51	1.75	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	207.75	47.87	7.44	0.46	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	266.49	59.22	6.99	0.82	0.00	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	283.93	23.94	3.38	1.23	0.31	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	361.00	115.64	11.52	1.71	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	318.46	111.61	10.62	3.64	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	363.95	129.02	11.31	4.57	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	266.40	99.56	14.70	5.79	1.34	0.89	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	285.85	95.06	12.01	3.67	0.67	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	215.55	87.34	16.72	7.43	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	265.92	82.11	8.29	8.29	1.13	1.13	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	666.85	141.74	9.16	4.36	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	20.62	1.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	197.82	44.27	8.48	0.00	0.71	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	201.03	71.51	13.03	0.31	0.47	0.31	0.00
adipose, donor1	10184-103D4	1569.23	378.82	25.80	1.17	7.04	21.70	6.45
adipose, donor2	10185-103D5	351.18	53.93	3.24	0.81	0.81	6.49	0.41
adipose, donor3	10186-103D6	435.39	89.04	9.26	2.45	1.36	3.81	1.91
adipose, donor4	10187-103D7	991.56	118.75	15.60	9.53	3.47	5.20	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	387.13	139.20	12.47	2.05	1.26	0.00	1.42
adrenal gland, adult, pool1	10081-102A9	101.85	10.91	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	447.98	93.38	11.47	2.00	0.53	1.60	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	542.38	118.62	29.30	1.43	2.86	3.57	1.79
amniotic membrane cells, donor1	12235-129G3	107.11	20.63	8.58	0.00	0.23	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	231.94	40.57	8.11	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	143.47	24.16	7.66	0.00	0.29	0.88	0.88
amygdala - adult, donor10196	10167-103B5	200.40	58.10	36.76	0.00	0.00	0.00	2.37
amygdala, adult, donor10252	10151-102I7	235.82	59.82	17.03	1.01	1.42	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	146.54	44.22	7.10	2.26	0.32	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	516.20	94.48	15.53	0.89	1.40	1.15	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	437.94	68.83	19.19	3.75	2.65	1.10	3.97
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	453.96	55.12	1.67	1.67	4.01	2.00	2.00
aorta, adult, pool1	10052-101G7	182.60	32.36	5.10	0.39	0.59	0.39	1.37
appendix, adult	10189-103D9	438.57	49.68	5.05	2.33	0.78	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	399.65	188.82	18.57	4.47	1.72	0.69	0.00
artery, adult	10190-103E1	167.12	33.97	6.79	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	179.06	55.63	10.00	0.72	0.00	0.14	0.00
b cell line:RPMI1788	10427-106D4	543.50	177.70	8.62	9.81	0.45	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	153.15	54.10	27.47	0.55	0.00	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	580.41	127.71	32.05	5.26	1.09	0.79	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	209.56	13.22	2.34	0.67	0.33	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	383.08	64.87	2.80	0.56	1.12	0.56	1.68
bladder, adult, pool1	10011-101C2	379.48	105.27	11.52	0.00	0.87	0.00	0.22
blood, adult, pool1	10053-101G8	516.01	44.29	15.50	4.43	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	144.72	45.39	18.84	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	238.21	103.92	21.59	0.67	0.00	0.00	1.35
brain, adult, donor1	10084-102B3	103.53	29.73	5.13	0.00	0.00	1.03	1.03
brain, adult, pool1	10012-101C3	211.14	71.60	23.83	0.22	0.45	0.67	0.22
brain, fetal, pool1	10085-102B4	104.18	40.07	0.00	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	592.34	107.70	11.23	0.99	0.99	0.99	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	219.69	52.68	3.25	0.00	0.00	0.00	0.62
breast, adult, donor1	10080-102A8	204.56	24.62	3.16	1.26	0.00	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	198.69	154.86	14.23	5.34	1.02	0.38	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	188.93	63.39	11.44	2.78	1.55	0.93	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	903.15	290.08	49.73	8.52	0.92	0.69	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	155.18	65.85	12.59	1.45	1.45	0.73	1.69
carcinoid cell line:NCI-H1770	10703-109H1	273.17	43.73	2.82	0.00	0.47	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	409.19	73.28	10.61	1.09	0.98	0.00	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	543.79	141.97	16.48	5.07	1.58	2.54	3.49
carcinosarcoma cell line:JHUCS-1	10642-109A3	605.02	239.56	18.63	2.40	1.86	0.80	1.60
caudate nucleus - adult, donor10196	10177-103C6	391.45	66.78	24.18	1.15	1.15	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	243.79	68.60	19.58	0.67	1.84	1.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	278.15	100.87	28.27	0.76	3.06	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	227.80	58.60	9.89	0.73	0.00	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	320.46	46.61	11.65	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	211.16	50.60	5.34	0.43	1.49	0.21	0.43
cerebellum, adult, pool1	10083-102B2	137.63	23.46	4.83	0.00	0.69	1.03	1.72
cerebellum, newborn, donor10223	10357-105E6	273.99	83.03	6.64	1.66	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	234.24	52.70	13.87	0.00	1.51	0.76	0.00
cerebrospinal fluid, donor2	10294-104G6	189.30	26.31	8.04	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	296.48	115.60	9.63	1.29	0.58	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	336.24	57.84	13.59	1.33	0.17	1.16	0.33
cervix, adult, pool1	10013-101C4	330.93	90.29	10.39	0.21	0.52	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	216.53	64.10	16.86	0.98	0.42	0.84	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	169.81	26.13	14.37	2.61	1.31	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	512.64	158.08	8.33	6.21	1.49	0.37	1.37
choriocarcinoma cell line:SCH	10785-110H2	432.85	60.99	4.19	2.59	2.34	0.99	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	348.18	24.90	0.24	1.90	0.00	0.24	1.19
chorionic membrane cells, donor1	12238-129G6	99.72	18.52	6.55	0.28	0.00	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	135.43	38.88	13.42	0.89	0.10	0.10	0.99
chorionic membrane cells, donor3	12240-129G8	89.02	26.92	9.89	0.00	2.20	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	293.85	112.09	10.10	4.04	0.00	3.03	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	328.49	68.39	11.72	4.23	0.77	1.34	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	84.90	35.69	4.65	1.48	0.84	0.42	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	313.30	107.60	19.77	8.47	0.51	0.26	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	387.25	123.36	24.91	8.95	1.21	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	352.04	116.67	28.51	11.81	0.20	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	373.66	189.63	28.86	12.66	0.59	2.65	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	237.95	92.00	11.73	3.65	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	281.16	151.09	25.37	3.66	0.69	1.14	1.14
clear cell carcinoma cell line:TEN	10636-108I6	583.85	111.22	11.28	3.12	1.21	0.69	0.69
colon carcinoma cell line:CACO-2	10513-107D9	298.36	90.61	12.26	10.62	0.55	0.73	0.55
colon carcinoma cell line:COLO-320	10420-106C6	581.52	227.67	6.84	6.46	1.14	0.38	0.00
colon, adult, donor1	10082-102B1	135.66	17.85	0.00	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	143.24	39.25	4.70	0.00	0.24	0.24	0.12
colon, fetal, donor1	10070-101I7	349.16	45.11	1.24	0.62	1.24	3.09	1.24
common myeloid progenitor CMP, donor1	12130-128D6	220.01	45.84	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	350.51	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	379.89	147.03	17.85	30.60	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	313.64	230.32	25.21	46.64	0.30	0.60	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	365.50	265.10	33.42	56.55	0.42	0.56	0.14
corpus callosum, adult, pool1	10042-101F6	278.62	51.74	3.54	0.33	0.22	0.00	0.00
cruciate ligament, donor2	10295-104G7	259.35	34.85	8.92	0.81	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	191.01	18.46	4.82	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	224.63	39.12	9.36	0.48	0.24	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1271.59	295.51	32.15	18.37	8.27	3.21	5.74
ductal cell carcinoma cell line:KLM-1	10438-106E6	216.69	90.01	13.85	1.54	0.26	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	374.56	39.48	12.04	1.93	0.24	1.20	0.00
ductus deferens, adult	10196-103E7	224.25	61.30	7.97	0.00	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	260.68	41.77	5.76	1.44	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	299.41	52.97	5.89	0.74	0.74	0.74	0.74
dura mater, adult, donor1	10041-101F5	216.30	87.54	13.05	0.58	0.41	0.00	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	215.19	39.97	13.10	65.29	0.00	0.67	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	272.26	109.76	19.49	6.16	0.14	1.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	417.45	57.96	12.33	6.78	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	509.76	75.68	18.16	4.84	1.51	1.21	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	447.07	59.59	8.95	13.89	0.93	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	601.57	56.48	9.19	10.51	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	454.53	63.35	13.74	23.13	1.34	1.68	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	632.87	113.63	19.94	2.72	3.44	1.09	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	230.45	51.78	9.97	0.32	0.80	0.32	0.80
epidermoid carcinoma cell line:A431	10426-106D3	318.36	73.03	17.45	2.78	0.11	0.44	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	302.13	74.35	24.97	1.65	0.22	0.00	0.33
epididymis, adult	10197-103E8	195.08	53.79	6.91	0.63	0.21	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	187.35	90.83	16.14	1.42	1.24	0.71	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	325.21	63.71	6.29	6.69	0.79	0.00	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	433.38	109.56	14.55	2.49	1.83	1.05	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	470.35	112.00	13.58	2.07	1.57	0.49	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	396.14	103.29	13.78	2.02	2.35	0.56	0.00
esophagus, adult, pool1	10015-101C6	227.96	60.63	9.13	0.11	0.21	0.32	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	507.71	207.89	13.65	1.63	0.50	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	154.53	28.97	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	193.59	37.88	10.52	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	81.85	14.88	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	159.36	34.39	5.73	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	199.66	37.89	11.66	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	277.62	53.90	6.10	0.00	0.51	0.25	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	302.74	83.86	34.49	9.75	2.31	1.15	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	360.40	96.87	27.78	10.21	1.90	1.42	2.14
frontal lobe, adult, pool1	10040-101F4	187.18	102.17	27.40	0.47	0.38	0.09	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	135.11	74.46	10.21	0.90	1.50	0.90	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	245.87	64.74	24.87	1.83	0.37	0.00	0.27
gall bladder, adult	10198-103E9	170.21	34.28	3.14	0.00	0.00	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	331.24	73.01	8.05	0.54	1.61	1.61	1.07
gamma delta positive T cells, donor2	11938-126A3	380.59	71.71	17.93	3.36	0.37	1.49	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	231.28	41.82	8.24	1.27	1.06	0.63	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	229.58	38.49	4.64	1.35	2.71	0.19	1.74
gastric cancer cell line:AZ521	10549-107H9	366.77	215.44	23.77	8.36	0.16	0.82	0.33
gastric cancer cell line:GSS	10560-108A2	643.40	240.70	12.81	1.83	0.00	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	809.42	128.62	13.02	0.91	2.97	0.46	1.37
giant cell carcinoma cell line:LU65	10487-107B1	257.71	31.67	10.90	2.41	0.23	0.57	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	379.29	134.92	23.37	8.96	0.14	0.00	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	208.26	48.89	9.23	0.50	1.25	0.00	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	315.92	114.10	32.93	9.82	0.84	0.53	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	297.31	103.64	23.73	8.29	1.54	1.54	0.56
glioblastoma cell line:T98G	10485-107A8	208.72	138.96	20.09	4.75	0.77	0.55	0.33
glioma cell line:GI-1	10413-106B8	398.02	65.31	10.54	1.46	0.29	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	351.34	29.89	8.02	1.46	1.46	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	456.21	44.18	6.59	0.98	1.71	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	231.40	47.92	12.32	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	204.64	34.11	6.40	2.13	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	261.84	17.13	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	273.21	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	271.78	47.04	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	306.56	45.12	19.52	0.00	1.28	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	476.56	95.50	10.10	16.53	0.92	0.46	2.30
hIPS +CCl2, biol_rep2	14384-156C1	445.37	87.79	10.06	12.80	0.00	0.91	1.83
hIPS +CCl2, biol_rep3	14385-156C2	384.52	73.43	9.66	10.31	0.64	0.64	3.86
hIPS, biol_rep1	14380-156B6	566.29	20.12	10.06	17.25	0.00	4.31	5.75
hIPS, biol_rep2	14381-156B7	424.55	47.32	6.86	9.60	0.69	2.74	6.17
hIPS, biol_rep3	14382-156B8	237.25	39.72	12.14	4.41	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	404.87	87.64	13.51	8.33	1.44	0.00	0.86
heart - mitral valve, adult	10205-103F7	238.58	56.50	11.96	0.90	2.09	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	229.31	76.09	8.89	0.00	0.52	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	333.06	23.31	3.33	4.16	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	172.22	40.20	9.59	0.41	0.61	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	163.52	34.07	4.68	0.43	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	191.80	32.66	6.67	0.00	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	421.19	93.44	9.24	0.41	0.00	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	200.23	37.64	20.98	1.23	0.31	0.31	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	929.94	143.89	8.32	3.57	2.38	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	274.25	80.88	9.83	12.15	1.55	0.33	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	307.44	80.71	11.89	14.08	0.97	0.36	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	307.50	88.62	11.62	15.46	0.81	0.30	0.40
hepatoma cell line:Li-7	10484-107A7	260.13	33.03	5.12	0.67	0.44	1.56	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	445.12	166.53	15.88	20.80	1.91	1.21	2.51
hippocampus - adult, donor10196	10169-103B7	246.05	52.05	31.23	0.00	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	254.10	57.56	13.47	0.61	2.65	1.02	0.20
hippocampus, adult, donor10258	10374-105G5	180.26	29.88	14.94	0.50	0.50	0.00	1.49
hippocampus, newborn, donor10223	10363-105F3	121.96	39.83	11.98	0.70	0.70	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1276.84	246.58	20.14	24.41	0.61	13.43	8.54
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	664.46	148.25	10.41	9.03	1.77	4.12	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	654.80	149.54	7.11	10.16	1.52	7.11	3.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	612.92	116.16	2.82	0.56	0.00	6.77	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	942.47	164.74	16.78	1.29	4.39	3.61	14.20
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	791.11	171.96	9.49	0.38	1.14	4.56	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	567.85	131.96	6.13	0.00	0.88	2.04	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	594.80	140.24	5.17	0.65	2.15	2.59	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	427.08	110.94	7.09	0.83	0.83	5.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	553.15	199.62	17.76	1.42	0.00	5.21	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	595.62	159.11	12.54	1.61	2.57	3.86	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	525.85	206.03	10.77	2.02	0.67	4.04	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	667.56	134.89	7.82	16.74	1.56	3.44	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	833.23	128.72	16.21	18.67	3.44	3.93	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1083.09	323.79	11.35	29.67	0.00	16.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	823.78	171.06	8.59	0.00	2.29	4.77	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	680.71	130.82	9.59	0.44	3.49	5.23	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	797.62	167.42	10.00	1.00	1.00	7.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	447.05	105.50	5.27	1.13	2.45	2.45	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	478.36	105.49	5.91	0.45	1.82	2.27	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	384.34	85.51	5.64	0.63	0.00	2.82	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	393.56	110.07	13.39	0.49	1.47	1.31	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	340.24	105.96	12.19	1.74	1.16	2.90	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	322.54	75.33	7.17	0.90	1.49	4.48	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	709.05	167.19	11.82	7.94	2.59	5.36	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	591.97	124.10	6.28	7.42	0.86	3.99	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	802.33	190.27	11.02	13.07	1.22	5.31	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	666.14	122.17	11.27	1.41	2.82	0.35	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	585.02	137.47	7.92	1.27	1.27	2.22	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	561.36	111.06	7.87	0.91	0.61	4.54	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	412.66	90.50	5.69	1.03	0.00	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	476.21	102.28	7.31	0.00	0.00	2.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	360.43	85.17	8.47	0.77	1.28	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	430.00	111.97	19.17	0.77	0.77	1.28	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	498.25	136.30	9.84	0.00	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	388.82	100.82	13.44	2.35	0.34	2.02	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	678.39	149.73	8.69	11.11	3.14	3.14	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	745.59	195.20	10.25	15.15	1.34	5.79	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	637.57	115.61	6.83	10.24	2.44	9.76	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	664.11	129.89	5.50	0.00	0.61	2.14	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6649.63	1486.73	61.81	3.25	3.25	16.27	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	865.75	192.94	7.94	1.65	2.32	4.96	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	542.92	105.63	2.74	1.09	2.19	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	460.68	107.12	7.24	0.36	1.45	2.17	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	427.76	98.58	3.56	1.07	1.42	3.20	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	495.25	137.24	5.97	0.00	1.19	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	571.22	199.62	17.88	2.30	0.95	1.08	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	393.05	92.94	7.54	1.62	0.27	5.93	1.35
immature langerhans cells, donor1	11904-125F5	529.82	122.77	20.58	2.18	0.24	0.24	1.70
immature langerhans cells, donor2	11905-125F6	159.22	46.74	2.38	3.17	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	164.85	93.12	20.72	0.00	0.28	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	166.48	23.09	7.48	0.98	0.33	0.00	0.33
kidney, adult, pool1	10017-101C8	139.08	50.46	6.61	0.20	0.20	0.20	0.10
kidney, fetal, pool1	10045-101F9	216.59	42.65	1.77	0.00	0.21	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	1137.45	164.18	34.51	10.94	1.42	0.85	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	542.18	18.80	4.70	0.14	1.38	0.97	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	588.12	51.01	7.89	1.83	0.92	0.18	1.28
left atrium, adult, donor1	10079-102A7	238.64	36.51	8.72	0.00	2.18	0.00	2.72
left ventricle, adult, donor1	10078-102A6	167.88	31.35	4.05	0.51	1.52	0.00	1.52
leiomyoblastoma cell line:G-402	10721-110A1	507.55	147.20	19.70	12.86	1.09	1.09	4.10
leiomyoma cell line:10964C	10569-108B2	151.96	54.97	21.91	1.08	0.00	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	132.07	45.65	21.74	3.26	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	153.95	65.80	23.07	2.19	0.73	0.97	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	241.28	63.49	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	440.18	59.60	18.82	1.05	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	281.57	58.32	16.88	4.37	1.18	0.00	0.59
liposarcoma cell line:KMLS-1	10782-110G8	193.23	42.96	19.21	3.91	0.47	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	231.49	56.78	14.26	3.17	1.58	0.85	1.71
liver, adult, pool1	10018-101C9	79.41	22.20	2.11	0.00	0.49	0.00	0.00
liver, fetal, pool1	10086-102B5	51.74	10.35	1.88	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	367.04	53.52	7.87	0.58	0.73	0.44	0.15
locus coeruleus, adult, donor10252	10165-103B3	227.92	38.20	7.38	0.18	1.11	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	180.85	28.78	6.77	0.56	2.26	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	339.44	63.51	7.99	1.26	1.26	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	403.70	55.22	4.43	2.49	0.42	0.83	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	143.40	83.42	15.17	0.69	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	268.11	95.30	19.11	4.09	0.00	0.26	0.40
lung, adult, pool1	10019-101D1	257.28	74.07	10.51	1.06	1.54	0.35	0.24
lung, fetal, donor1	10068-101I5	331.07	157.26	21.12	2.00	0.29	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	177.33	28.87	2.75	0.00	2.75	0.00	2.29
lymph node, adult, donor1	10077-102A5	305.32	39.76	8.99	0.95	0.95	1.42	2.84
lymphangiectasia cell line:DS-1	10727-110A7	560.66	85.48	6.79	4.38	2.63	3.07	2.19
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	704.07	169.04	14.34	34.11	1.06	1.21	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	193.68	65.41	8.49	0.85	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	128.76	50.61	5.77	1.33	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	171.21	64.75	4.77	0.62	0.42	0.62	0.21
mature adipocyte, donor3	12233-129G1	156.46	82.50	11.14	1.42	0.24	0.24	0.24
mature adipocyte, donor4	12234-129G2	200.31	120.29	8.95	0.53	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	671.65	136.76	17.39	1.43	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	236.89	60.91	19.18	0.00	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	251.40	69.70	24.09	0.00	1.29	0.37	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	168.69	43.52	17.79	0.00	0.64	0.64	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	356.12	144.58	58.86	5.97	1.71	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	345.94	101.25	39.99	1.01	2.19	0.34	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	237.05	68.55	19.52	0.00	1.27	0.64	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	142.54	34.67	34.67	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	3889.83	1004.75	401.90	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	132.80	50.97	8.61	0.72	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	264.78	24.01	5.19	2.60	0.65	0.00	2.60
medulla oblongata, adult, donor10252	10155-103A2	304.34	47.52	7.89	0.46	0.93	0.31	0.31
medulla oblongata, adult, pool1	10038-101F2	200.56	55.42	7.75	0.24	0.57	0.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	248.58	30.90	7.29	0.00	0.00	1.39	0.69
medulloblastoma cell line:D283 Med	10838-111E1	1202.27	131.74	14.83	7.53	5.98	1.11	2.21
medulloblastoma cell line:ONS-76	10759-110E3	180.72	60.53	13.08	4.04	1.10	0.49	0.49
melanoma cell line:COLO 679	10514-107E1	234.59	103.50	16.10	5.32	0.29	0.29	0.00
melanoma cell line:G-361	10465-106H6	148.49	59.18	10.32	2.17	0.54	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	331.24	40.16	14.11	1.99	1.63	0.90	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	401.81	160.37	15.86	0.88	0.00	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	177.05	71.29	9.33	0.52	0.00	1.04	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	137.17	53.55	24.86	3.07	0.15	0.31	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	187.60	39.45	13.82	2.91	0.36	0.18	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	90.69	44.72	17.39	2.90	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	150.31	32.03	16.86	0.42	0.28	0.70	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	157.91	27.54	10.98	0.77	0.39	0.39	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	95.09	40.95	11.11	1.39	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	207.68	38.45	17.34	2.06	0.51	0.00	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	175.86	32.09	15.41	1.38	0.23	0.23	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	128.66	39.79	17.38	2.65	0.00	0.00	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	122.08	46.86	24.85	2.57	0.54	0.41	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	137.99	43.39	18.35	1.42	0.28	0.14	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	200.91	33.59	9.55	0.66	0.33	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	133.25	40.40	18.40	0.83	0.42	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	150.11	40.84	18.15	2.44	0.70	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	165.17	44.71	20.62	1.84	0.61	0.82	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	183.68	36.30	13.30	0.72	1.44	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	129.62	37.35	15.62	0.52	0.00	0.21	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	99.18	29.87	15.96	0.91	0.46	0.23	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	122.93	79.30	36.50	4.20	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	125.23	29.89	15.99	0.75	0.15	0.15	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	178.30	36.59	12.08	0.88	0.18	0.26	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	286.80	38.29	20.99	0.37	0.74	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	189.44	34.63	17.17	0.86	0.00	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	625.63	204.19	66.94	7.58	3.79	3.37	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	137.00	28.77	12.79	0.46	0.00	0.00	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	177.26	37.86	13.05	0.51	0.51	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	165.69	36.38	11.78	0.00	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	176.23	31.73	11.09	0.00	1.54	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	182.64	41.66	18.83	0.47	0.47	0.24	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	169.91	44.34	15.57	0.68	0.34	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	170.55	37.33	9.82	0.00	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	173.77	41.70	10.19	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	228.43	47.30	22.21	0.00	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	160.19	38.82	12.27	0.45	0.45	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	172.81	42.30	13.46	0.72	1.20	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	267.66	42.53	23.47	0.73	0.73	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	159.10	40.61	10.41	1.01	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	182.17	42.17	13.92	1.23	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	173.54	43.81	9.02	0.86	0.00	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	216.02	38.28	19.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	211.76	36.15	15.49	0.00	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	198.44	34.75	7.47	0.32	0.32	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	248.80	30.55	7.27	0.00	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	223.36	28.79	14.39	2.13	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	217.53	35.98	9.00	2.45	0.82	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	207.58	34.21	8.55	0.00	1.17	0.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	232.96	48.27	8.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	234.46	39.74	13.91	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	209.76	33.37	14.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	211.10	34.39	10.08	0.59	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	297.30	45.08	9.75	0.00	1.22	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	243.47	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	228.02	32.30	16.47	0.63	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	275.92	50.36	12.42	0.69	0.69	2.07	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	270.80	47.28	12.90	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	351.28	43.91	23.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	340.94	30.99	20.66	0.00	3.44	6.89	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	357.35	42.78	13.45	1.22	0.81	2.04	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	396.43	46.87	11.92	0.79	0.79	1.59	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	424.46	34.78	12.97	0.59	1.18	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	399.92	33.35	13.09	1.25	1.56	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	493.23	40.10	9.36	1.34	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	235.35	48.49	8.28	1.18	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	351.82	46.22	23.11	0.00	10.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	293.95	57.14	14.46	3.44	2.07	0.69	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	99.95	33.15	4.45	1.48	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	105.42	30.28	1.12	0.00	1.12	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	120.85	24.81	2.54	0.00	0.64	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	54.00	16.12	1.21	0.40	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	13.08	4.36	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	65.89	10.14	0.00	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	56.44	19.42	5.46	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	99.42	18.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	75.78	14.83	3.29	0.82	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	134.14	35.32	7.34	0.60	0.00	1.19	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	140.18	22.39	6.17	0.65	0.32	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	158.91	32.60	7.13	0.00	2.04	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	300.97	54.93	9.28	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	401.85	112.45	20.55	6.38	0.71	0.94	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	151.51	104.95	10.43	3.71	0.46	1.62	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	337.61	72.65	25.64	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	423.02	109.63	29.49	3.29	1.44	0.10	0.62
mesothelioma cell line:Mero-25	10850-111F4	298.67	36.31	4.31	5.67	1.59	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	624.39	140.82	49.87	5.87	4.40	0.49	0.98
mesothelioma cell line:Mero-48a	10852-111F6	257.52	55.58	24.14	2.44	1.33	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	392.11	60.97	24.97	4.20	2.63	0.79	3.15
mesothelioma cell line:Mero-83	10854-111F8	484.45	71.15	19.92	4.26	2.72	0.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	141.30	52.07	6.82	0.00	0.25	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	226.09	46.58	12.22	3.11	1.24	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	380.82	95.91	42.90	8.45	2.32	0.99	1.33
mesothelioma cell line:NCI-H226	10846-111E9	525.06	129.41	51.94	15.20	2.90	1.45	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	355.65	123.68	42.19	4.78	1.37	0.34	1.02
mesothelioma cell line:NCI-H28	10845-111E8	428.27	99.24	14.76	5.60	0.51	0.76	1.27
mesothelioma cell line:No36	10857-111G2	338.27	58.39	11.42	1.63	0.98	0.65	1.30
mesothelioma cell line:ONE58	10858-111G3	217.30	80.47	21.13	2.17	0.81	0.00	1.35
migratory langerhans cells, donor1	11901-125F2	586.90	212.07	23.80	1.15	0.00	0.00	0.77
migratory langerhans cells, donor2	11902-125F3	334.35	128.71	13.80	0.49	0.12	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	807.48	203.53	24.77	0.72	0.36	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	285.34	34.28	8.16	0.33	2.94	0.33	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	354.99	39.84	9.11	2.54	1.27	1.27	2.76
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	500.80	73.02	16.82	3.23	1.38	0.23	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	219.03	77.45	5.14	7.80	0.57	0.95	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	414.67	83.16	4.99	1.11	0.92	0.37	0.00
myeloma cell line:PCM6	10474-106I6	179.28	43.29	4.55	2.17	0.20	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	475.33	70.51	25.36	3.04	2.03	0.51	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	165.54	28.64	24.32	0.39	1.18	0.39	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	176.27	24.07	7.69	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	255.99	27.28	8.38	0.37	0.15	0.29	0.29
nasal epithelial cells, donor2	12227-129F4	293.66	24.29	9.38	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	767.71	232.59	14.49	4.83	0.23	0.92	0.69
neuroblastoma cell line:NB-1	10539-107G8	120.30	60.05	4.68	1.50	0.19	1.12	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	422.62	37.54	5.06	5.06	1.05	1.05	1.05
neuroblastoma cell line:NH-12	10555-107I6	992.69	159.89	10.62	3.91	3.54	0.93	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	820.33	190.25	6.88	1.42	4.51	0.95	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	714.93	98.35	11.25	3.64	3.33	2.22	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	402.92	68.23	3.62	3.02	1.01	1.21	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	269.56	90.91	6.99	3.81	0.64	0.64	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	221.18	47.64	15.44	2.40	0.27	1.06	0.27
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	18.94	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	774.40	393.54	15.90	3.38	0.51	0.00	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	397.85	121.68	20.01	0.00	0.00	4.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	184.03	58.67	25.01	1.92	0.64	0.64	3.21
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	141.89	60.17	11.30	1.31	0.53	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	206.32	94.77	20.62	0.47	0.19	0.09	0.19
occipital cortex - adult, donor10196	10172-103C1	381.17	63.87	28.85	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	299.49	60.11	13.69	0.54	2.15	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	180.52	62.23	14.56	1.09	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	254.79	47.49	21.52	0.00	1.31	1.84	1.84
occipital lobe, fetal, donor1	10073-102A1	341.13	54.50	5.15	0.86	2.15	0.86	3.43
occipital pole, adult, pool1	10036-101E9	108.96	40.60	5.76	0.08	0.00	0.08	0.08
olfactory region, adult	10195-103E6	187.61	54.45	16.62	0.57	1.15	0.38	0.38
optic nerve, donor1	10277-104E7	494.26	30.02	6.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	247.86	34.06	6.61	3.99	0.34	0.57	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	264.61	83.94	5.63	4.95	0.41	0.27	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	412.64	66.71	16.76	0.51	3.05	0.51	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	378.52	24.95	6.82	0.46	1.27	0.23	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	189.90	29.98	8.82	0.88	0.29	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	614.79	117.73	31.77	7.47	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	252.35	57.47	3.61	1.06	0.00	0.64	0.00
ovary, adult, pool1	10020-101D2	471.96	52.15	4.98	0.26	0.96	0.26	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	320.99	37.76	19.62	2.93	1.83	0.37	2.93
pancreas, adult, donor1	10049-101G4	129.81	23.52	0.94	0.00	0.00	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1418.36	177.23	10.62	1.12	6.15	4.19	5.59
papillary adenocarcinoma cell line:8505C	10437-106E5	492.15	83.81	23.68	2.38	3.58	1.02	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	370.41	51.83	12.75	1.49	0.50	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	170.60	77.15	19.13	0.46	0.27	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	288.46	44.04	16.88	0.73	1.47	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	277.44	48.91	26.33	0.00	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	234.02	71.54	17.10	0.29	2.57	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	153.95	64.59	14.01	0.26	0.35	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	391.81	103.77	8.73	3.88	2.91	0.00	5.82
parietal lobe, newborn, donor10223	10356-105E5	186.93	78.51	15.70	2.99	0.00	0.37	0.00
parotid gland, adult	10199-103F1	172.05	22.82	0.62	0.62	0.62	0.62	0.62
penis, adult	10200-103F2	229.35	47.27	8.59	0.00	1.61	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	527.13	74.00	7.07	1.12	0.74	0.37	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	127.63	28.26	4.81	0.73	1.31	0.15	0.73
pineal gland - adult, donor10196	10179-103C8	108.36	23.87	9.68	0.00	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	218.53	49.75	8.29	0.59	0.59	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	95.32	39.51	7.52	0.63	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	384.48	54.64	18.21	1.01	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	490.43	95.38	16.16	0.52	1.56	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	305.60	68.10	9.36	0.00	1.70	0.85	0.00
placenta, adult, pool1	10021-101D3	109.44	51.92	7.53	0.32	0.43	0.00	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	441.64	81.05	10.46	17.22	1.85	0.79	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	308.94	70.66	12.61	0.47	0.78	0.62	0.31
pons, adult, pool1	10033-101E6	173.00	68.34	14.72	0.43	0.34	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	162.06	55.36	12.03	0.09	0.17	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	108.75	8.37	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	396.58	38.56	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	281.66	23.47	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	293.95	130.08	22.29	9.03	1.46	1.89	0.44
prostate cancer cell line:PC-3	10439-106E7	202.01	83.31	18.15	4.54	1.82	0.73	0.54
prostate, adult, pool1	10022-101D4	275.34	74.55	6.62	0.27	0.45	0.09	0.09
putamen, adult, donor10196	10176-103C5	265.57	104.10	37.53	1.18	2.60	0.94	0.24
putamen, adult, donor10252	10152-102I8	358.81	50.98	13.73	1.96	3.92	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	318.01	46.99	18.58	5.46	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	271.33	68.86	23.68	0.48	2.42	1.21	1.45
putamen, newborn, donor10223	10365-105F5	309.61	91.46	17.24	2.25	0.00	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	346.21	69.24	3.78	1.45	1.16	0.29	0.29
rectum, fetal, donor1	10067-101I4	575.87	75.11	9.74	0.00	1.39	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	325.42	162.81	47.91	5.94	0.21	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	384.80	111.01	7.04	4.14	0.83	0.83	0.41
retina, adult, pool1	10030-101E3	190.65	50.10	5.37	0.00	0.20	0.10	0.00
retinoblastoma cell line:Y79	10475-106I7	799.93	300.85	13.51	3.64	1.04	2.60	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	292.86	113.36	19.18	6.52	2.46	1.23	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	795.80	272.76	17.15	10.69	1.69	0.56	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	273.59	75.03	11.37	0.76	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	499.17	53.25	16.83	6.31	2.43	0.65	0.81
salivary acinar cells, donor2	11772-123I8	572.37	35.39	13.91	4.68	2.48	0.14	0.55
salivary acinar cells, donor3	11773-123I9	349.56	21.85	8.61	0.66	1.32	0.00	1.32
salivary gland, adult, pool1	10093-102C3	125.83	29.74	3.43	0.00	0.00	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	325.11	78.16	23.27	1.18	0.59	0.25	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	312.34	62.89	16.69	1.29	0.12	0.82	0.24
seminal vesicle, adult	10201-103F3	193.64	45.50	10.05	0.53	1.59	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	151.34	54.17	10.20	1.94	0.24	1.46	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	327.12	44.79	13.34	0.00	0.25	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	271.96	85.30	36.13	1.00	1.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	329.89	39.09	7.79	0.40	0.81	0.54	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	233.02	104.90	15.35	3.74	0.13	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	212.09	51.07	8.51	0.00	1.42	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	341.46	88.99	13.07	0.12	0.96	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	208.04	27.14	3.02	0.00	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	135.70	20.36	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	309.93	43.55	7.57	0.63	0.63	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	128.07	115.73	12.67	1.67	1.67	1.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	288.41	85.74	13.55	0.63	1.26	0.32	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	644.74	75.17	10.41	4.82	1.73	1.35	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	425.91	267.02	18.63	7.09	0.82	0.33	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1567.00	131.74	7.72	2.25	4.34	3.22	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	288.96	73.44	15.04	0.87	1.09	0.44	1.31
small intestine, adult, pool1	10024-101D6	95.32	35.24	2.51	0.00	0.12	0.00	0.00
small intestine, fetal, donor1	10064-101I1	223.83	37.84	5.90	0.25	0.74	0.25	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	126.69	59.50	8.21	0.00	0.00	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	326.95	64.87	5.94	0.26	1.55	0.52	1.03
somatostatinoma cell line:QGP-1	10781-110G7	66.74	13.94	1.61	0.54	0.54	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	455.14	53.45	12.62	0.69	1.84	0.00	0.69
spinal cord, adult, donor10252	10159-103A6	425.81	69.00	9.07	0.79	1.58	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	403.32	40.12	11.07	0.69	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	255.52	37.81	5.49	0.61	2.44	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	459.21	48.68	5.97	0.92	1.38	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	133.37	33.01	16.43	1.05	1.05	0.00	1.19
spleen, adult, pool1	10025-101D7	266.75	60.24	6.28	3.30	0.66	0.33	0.11
spleen, fetal, pool1	10044-101F8	205.87	43.70	2.78	1.27	0.24	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	515.91	221.00	20.81	19.87	0.83	0.93	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	323.74	47.66	6.65	1.33	1.33	0.57	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	214.21	78.63	10.48	0.70	0.00	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	282.64	25.02	9.38	2.35	1.95	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	190.67	40.30	9.12	2.03	0.11	1.01	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	211.80	29.65	4.66	0.85	0.42	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	175.15	70.23	16.08	3.81	0.00	0.42	0.42
stomach, fetal, donor1	10062-101H8	253.11	46.99	6.41	3.20	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	228.44	29.05	6.27	1.14	1.14	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	2279.51	379.92	217.10	54.27	162.82	0.00	325.64
substantia nigra, adult, donor10252	10158-103A5	346.45	45.90	5.19	0.21	0.62	2.28	0.42
substantia nigra, adult, donor10258	10371-105G2	193.45	28.97	5.69	0.52	0.00	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	249.42	36.04	4.24	0.00	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	275.12	132.97	15.59	3.44	1.60	1.83	0.46
temporal lobe, adult, pool1	10031-101E4	122.24	42.05	7.71	0.08	0.08	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	298.44	47.72	4.99	0.71	0.00	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	251.42	46.15	7.03	0.00	2.20	0.44	0.00
tenocyte, donor1	11763-123H8	176.99	35.96	17.11	1.05	2.44	0.00	0.35
tenocyte, donor2	11765-123I1	200.29	39.68	12.97	0.00	1.14	0.76	2.29
tenocyte, donor3	11768-123I4	144.19	45.22	28.91	0.00	0.00	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	489.49	148.72	11.90	22.43	1.53	1.36	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	637.87	84.47	7.40	2.31	1.70	3.24	3.70
teratocarcinoma cell line:PA-1	10807-111A6	561.02	135.92	9.61	13.64	2.48	2.17	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	657.46	146.62	16.12	6.98	3.81	1.40	2.67
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1036.95	177.74	9.83	3.03	2.27	1.89	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1162.17	257.71	14.07	5.13	2.07	0.22	3.27
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	552.39	266.42	16.29	6.51	4.23	0.65	1.30
testis, adult, pool1	10026-101D8	238.80	69.68	8.16	1.93	0.00	0.21	0.11
testis, adult, pool2	10096-102C6	197.12	44.66	4.96	5.41	1.35	0.45	0.45
thalamus - adult, donor10196	10168-103B6	381.98	35.33	11.04	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	347.57	53.45	7.50	0.31	1.09	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	244.80	10.78	10.78	1.54	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	143.94	25.03	7.91	0.00	0.82	0.49	0.99
thalamus, newborn, donor10223	10366-105F6	163.97	48.90	20.14	0.58	0.00	0.58	0.00
throat, adult	10209-103G2	211.22	30.21	4.99	0.25	0.00	0.25	0.00
throat, fetal, donor1	10061-101H7	272.10	52.41	7.92	0.91	3.35	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	643.10	195.75	20.47	7.75	1.79	0.99	0.20
thymus, adult, pool1	10027-101D9	459.30	153.89	9.15	0.40	0.40	0.00	0.10
thymus, fetal, pool1	10043-101F7	338.52	108.48	8.73	0.62	0.00	0.10	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	254.89	64.88	22.20	1.86	0.53	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	522.30	72.08	18.86	0.56	3.21	0.56	3.35
thyroid, adult, pool1	10028-101E1	254.00	69.70	6.25	0.09	0.37	0.00	0.09
thyroid, fetal, donor1	10060-101H6	161.36	33.49	5.54	0.26	2.37	0.79	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	104.71	24.64	6.16	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	181.41	41.17	9.07	0.00	0.23	0.23	0.00
tongue, fetal, donor1	10059-101H5	212.81	33.89	4.73	0.79	0.00	0.00	1.58
tonsil, adult, pool1	10047-101G2	245.43	61.41	4.91	0.70	0.10	0.00	0.00
trachea, adult, pool1	10029-101E2	219.79	54.48	15.71	0.49	0.08	0.08	0.16
trachea, fetal, donor1	10058-101H4	288.52	47.32	7.31	0.00	1.92	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	148.80	56.33	17.71	2.13	1.42	0.71	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	237.59	71.33	19.76	2.84	0.30	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	351.76	113.91	12.85	3.92	0.31	1.41	0.31
tridermal teratoma cell line:HGRT	10694-109G1	302.50	62.78	26.64	1.90	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	258.35	46.47	7.28	1.02	0.59	0.17	1.02
umbilical cord, fetal, donor1	10057-101H3	175.27	31.30	4.17	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	224.38	65.18	8.19	0.00	0.00	0.17	0.34
uterus, fetal, donor1	10055-101H1	567.22	74.23	7.17	0.00	5.63	2.56	1.02
vagina, adult	10204-103F6	429.08	43.30	3.23	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	269.18	45.59	3.51	0.00	0.66	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	340.47	92.66	8.81	8.28	2.67	0.27	1.34